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Summary 
 
This working paper was originally prepared for a High Level meeting on scaling-up insecticide 
treated net coverage convened by the United Nations Foundation (UNF) in Paris on 7 September 
2005 as a follow-up to an initial meeting convened by UNF and the Canadian International 
Development Agency (CIDA)in Geneva,  on 23 June, 2005. The purpose of the meeting (Minutes 
attached, see Annex 1) was to discuss the feasibility of a rapid scale-up ("quick win") to protect 
all pregnant women and children under five years by 2010 with insecticide treated nets (ITNs) 
with an emphasis on long lasting insecticidal nets (LLINs). This document aims to provide a basis 
for planning for such a scale-up by evaluating the future commodity and operational costs 
associated with providing universal coverage with ITNs for pregnant women and children under 
five years in malaria endemic areas of Africa.  Following the recommendations of the meeting 
on 7 September 2005, the working paper has been revised based on comments from participants 
in that meeting, members of the Roll Back Malaria Partnership Working Group on Insecticide-
treated Nets (WIN), WHO and UNICEF staff working on malaria control and vector control as 
well as other partners.  It is now published on the web so as to provide benchmark figures on 
commodity needs and funding needs, against which actual implementation can be gauged.   
 
The advantages and disadvantages of alternative delivery channels are explored. Technical and 
epidemiological rationale are used to conclude that the best way to achieve universal coverage 
is to build universal provision through routine services, antenatal clinics (ANC) and the 
Expanded Programme on Immunization (EPI), as the primary method of delivery. Whilst these 
routine health system-based delivery channels will cover the majority, it is recognized that 
they should be complemented by other channels, EPI outreach, community based systems 
and/or Child Health Days/Weeks (CHD/W), with which to reach those who do not access these 
routine ANC and EPI services. The combination of these systems provides a ‘keep-up’ of 
sustained delivery of ITNs. 
 
Combined delivery of ITNs with immunization campaigns has recently provided an exciting 
opportunity for rapid scale-up of equitable ITN coverage as shown in a number of countries. 
Whilst recognizing the advantages of this channel as a quick-fix ‘catch-up’ delivery system, the 
disadvantages of the ‘transient’ coverage achieved are outlined as the reason that such 
campaigns are most useful as a complement to routine systems. In countries where routine 
systems are very weak, such as those in complex emergencies, campaigns may be the best way 
to deliver ITNs in the longer term, until health systems become stronger. 
 
(Re) treatment campaigns are proposed as a way of rapidly scaling-up coverage of ITNs in 
countries where there is relatively good coverage with mosquito nets. 
 
Donors considering investing in one or other of these systems should consider giving long-term 
support for routine services, which are better able to address the challenge of providing 
continuous coverage to pregnant women and children under five years with ITNs.  This kind of 
support may help substantially in the long-time priority of strengthening health systems.  
 
The numbers of ITNs needed to cover the target population of pregnant women (25.6 million) 
and children under five years (109.7 million) at risk of malaria in Africa are calculated, using a 
mix of delivery channels. Cost data from previous studies on ITN programmes are used to 
estimate the funds needed to deliver this number of ITNs over a five year period. These 
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estimates are simplistic and much more detailed costing is required to gain more accurate 
figures.  
 
However, using the methods and assumptions outlined in the report and taking into account the 
simplistic nature of our methods, we estimate that 312.3 million ITNs are required to deliver to 
the target group over a five year period through ANC, EPI and planned measles campaigns, at a 
cost of US$ 2.27 billion.  
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This paper, commissioned by WHO, has been prepared by scientists of the London School of 
Hygiene and Tropical Medicine with inputs from staff from a number of organizations, 
institutions and partners, including Centers for Disease Control and Prevention, Atlanta, USA, 
UNICEF, WHO, the Roll Back Malaria Partnership Secretariat and the Roll Back Malaria Working 
Group on Insecticide-Treated Nets.  The views expressed in the paper do not necessarily reflect 
the policies of WHO and statements regarding countries, their borders and populations do not 
imply the expression of any opinion on the part of WHO.  This document represents "work in 
progress" and should not be quoted or disseminated without the agreement of WHO. Queries 
should be addressed to Dr M. K. Cham, Global Malaria Programme (chamm@who.int).    
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1.  Introduction 
In 2000, African Heads of State and Government agreed to seek to  achieve that "at least 60% of 
those at risk of malaria, particularly pregnant women and children under five years, benefit 
from the most suitable combination of personal and community protective measures such as 
insecticide treated mosquito nets" by 2005.1  It became clear already in 2004 that with baseline 
coverage rates for insecticide treated nets (ITNs) as low as 2-3% in most African countries 
measured between 1997 and 20012, it would not be possible to meet the target, mainly as a 
result of insufficient funding, but also on the background of inadequate planning and 
organization.  Increased international attention to Roll Back Malaria and the emergence of huge 
production of inexpensive LLINs, which could make ITN operations easier to manage and 
maintain and more cost-effective created an environment, where the rapid scale-up of ITN 
coverage was seen as the most realistic "quick-win" for the Roll Back Malaria movement, which 
could save lives and restore confidence.  After various initial contacts, The United Nations 
Foundation (UNF) and the Canadian International Development Agency (CIDA) convened a ‘High 
Level’ meeting in Geneva, June 23, 2005, which was followed by a second meeting convened by 
UNF in Paris on 7 September 2005. The purpose of the meetings was to discuss the feasibility of 
and requirements for a rapid scale-up to protect all pregnant women and children under five 
years by 2010 with ITNs with an emphasis on LLINs. The Minutes of the second meeting are 
attached (Annex 1).  Following the recommendations of the meeting on 7 September, the 
working paper has been revised based on comments from participants in that meeting, 
members of the Roll Back Malaria Partnership Working Group on Insecticide-treated Nets (WIN), 
WHO and UNICEF staff working on malaria control and vector control as well as other partners. 
 
Achieving universal coverage is an ambitious goal as only a few African countries (Eritrea and 
Togo) have thus far achieved the Abuja target, although a number of others, especially in East 
Africa, have made excellent progress also. Broadly speaking, coverage successes were attained 
using a number of different strategies and delivery systems, highlighting the need for 
adaptation of a mix of strategies to local circumstances.  The lessons learnt now need to be put 
into practice on a much larger scale, supported by stronger donor commitment to sustained 
investment and supplemented by emerging new strategies to expand coverage across 
geographic and economic strata.   
 
This document aims to provide a basis for strategic planning by evaluating the future 
commodity and operational costs associated with providing universal coverage with ITNs for 
pregnant women and children under five years in malaria endemic areas of Africa.  This 
document also reviews the advantages of a number of delivery models, particularly ANC, EPI, 
and immunization campaigns. To date, the choice between models has been constrained by a 
shortage of ITNs (and funding for ITNs), and influenced by preferences for short-term funding 
and quick results within defined geographic areas. A subsidiary aim of the document therefore, 
is to consider how the public health benefits of donor funding can be maximized.     
  
Donor interest in ITN scaling-up has recently been invigorated by pilot campaigns in which ITN 
distribution is combined with vaccination programmes, especially measles campaigns.  As many 
country ITN distribution programmes have marked geographical and socio-economic inequities 
in ITN coverage, campaign-based distribution of ITNs is one of several options that may help 
redress these inequities.   These intensive short-term campaigns may prove more attractive to 
some donor groups than supporting routine service delivery of ITNs.  The relative advantages 
and costs associated with campaign delivery of ITNs and routine public health service ITN 
delivery such as ante-natal care (ANC) and immunization (EPI) will also be presented. It is 
hoped that new initiatives in ITN scaling-up will provide universal sustained coverage to 
pregnant women and children under five years.    
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It is therefore concluded that a mix of delivery systems will be needed to achieve complete and 
sustained coverage, with no one single delivery system achieving complete coverage on its own.  
Each distribution system can reach segments of the target groups not reached by the others.   
An integrated approach to ITN distribution should build on and strengthen existing local 
distribution and supply systems, including the commercial and public health channels. Ghana, 
Kenya, Nigeria and United Republic of Tanzania are all planning to combine more than one 
method of delivering free and/or highly subsidized ITNs, with various types and degrees of 
commercial sector involvement. The balance of this mix will certainly vary between countries, 
and may also vary from one province to another within a country, and may change over time.      
 
For this initial stage of planning, this document first reviews the types of mosquito nets 
available including the process by which LLINs are tested and evaluated.  Then, the strengths 
and weaknesses of the various distribution systems are outlined and how these can be 
combined, taking into account prospects for new technology, likely constraints in supply, and 
the opportunities offered by local net suppliers and distributors.      
 
The approach presented for costing is admittedly simplistic and provisional.  Previous attempts 
to estimate the expected cost of scaling-up ITN coverage in Africa used a wide variety of 
approaches and assumptions, and the resulting estimates range between US$258 million to 
US$1.66 billion.  This review builds on these previous estimates and suggestions are offered as 
to the recurrent funding needed to maintain full coverage, and the catch-up funding that will 
be needed to reach this target at an accelerated pace.  For present purposes, very simple and 
general assumptions are made about how routine and campaign delivery systems are to be 
combined, but it is emphasized that more detailed plans will have to take account of country-
specific overlaps and complementarities in order to maximize coverage. This paper aims to 
provide a simplified analysis as a basis for a feasible strategy to protect all pregnant women 
and children under five years at risk from malaria. 
2. Technical issues  
This analysis is limited to consideration of the costs and benefits of distribution systems for ITNs 
to pregnant women and children under five years in Africa.  Before considering the costs 
associated with distribution systems, a brief overview of ITNs and LLINs is presented.  This 
includes (re)treatment of conventional nets and the process by which a new insecticide treated 
net is recommended for public health use.  Two parameters having key impact on the costs of 
distribution systems are the life of the net fabric and the effective life of the insecticide with 
which the net is treated.    
2.1 Effective life of the net fabric 
There is a paucity of detailed data on how long nets last.  However, there is a growing body of 
evidence that the lifespan of conventional nets made of 75 or 100 denier multifilament knitted 
polyester varies widely from place to place and from house to house, and that 2 or 3 years is 
probably a realistic estimate of the average life of the net fabric.   Nets made of polyethylene, 
such as the Olyset™ net, are likely to have a longer structural life. This has important 
implications for planning and cost estimates.   Traditional nets, made from a variety of fabrics, 
are commonly used in rural areas in West Africa and Madagascar.  These nets are estimated to 
last 6 years on average3.  
2.2. LLIN Products:  
There are two currently-available WHOPES-recommended LLINs.  They differ from one another 
in both their physical properties and the technology used to extend the effective life of the 
insecticide.  The Olyset™ LLIN is a more wide-mesh net made of a monofilament of 
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polyethylene with permethrin incorporated into the body of the fibre.  The PermaNet™, by 
contrast, is a conventional knitted spun polyester fibre net coated with a special deltamethrin 
resin.  One significant difference between these two LLINs is the need for regeneration 
(diffusion of the insecticide to the surface that is temperature dependent) after washing by the 
Olyset™ net in order to benefit from full insecticidal properties.  Differences in their 
performance are emerging as they are evaluated under a wide range of conditions.  Costs for 
the available sizes of LLINs are given on the RBM website with "family-sized" nets costing around 
US$5.10 (Olyset®) and US$4.00 (PermaNet®).  Both companies are currently increasing sharply 
their LLIN production capacity.   
 
The technology of LLINs is rapidly evolving.  The large developing market for new LLINs will 
encourage market entry by new products.  Strict quality control standards are necessary to 
ensure both safety for the user and efficacy as a public health tool in both the recommendation 
process by the World Health Organization Pesticide Evaluation Scheme (WHOPES) and in the 
subsequent quality assurance processes. The WHOPES evaluation process of a new LLIN and its 
requirements is reviewed below.  
2.3. WHOPES Recommendation and Importation of LLINs 
WHOPES is the only international programme that promotes and coordinates the testing and 
evaluation of pesticides for public health use4. These steps are necessary to ensure both the 
safety and efficacy of the product to the user as well as the confidentiality of the 
manufacturing process for the producer.  An important aspect is that the procedure and 
requirements by which a product receives a WHOPES recommendation is developed in 
consultation and agreement with industry together with national disease control programmes, 
pesticide regulatory authorities and other international and regional organizations and 
institutions.  
 
The WHOPES four-phase testing and evaluation of LLINs can be summarized as follows.  Phase 1 
entails determination of efficacy and wash resistance of a LLIN and study of dynamics of the 
insecticide on the fibre.  It also includes an evaluation with the WHO Programme on Chemical 
Safety on safety for humans and the environment.  Phase 2 involves small-scale field studies 
under well controlled conditions to determine efficacy of LLIN in terms of blood-feeding 
inhibition, deterrence, induced exophily and mortality as well as recording perceived side-
effects of LLIN among users.  Phase 3 involves assessment of the efficacy, longevity and fabric 
integrity as well as community acceptance of a LLIN. During Phase 4 specifications for the 
product are established and subsequently updated as needed (see WHO specifications for 
pesticides at http://www.who.int/whopes/quality/en/). 
 
In view of the long-term studies that may be required to fully test or evaluate a LLIN product, 
interim recommendations on its use may be given subject to the following: use of WHO-
recommended insecticides in making the LLIN; satisfactory completion of laboratory and small-
scale field testing; and confirmation that after at least 20 standard WHO washes the LLIN 
performs equal to or better than a conventionally treated net washed until just before 
exhaustion.  A LLIN is given a full recommendation when it meets Phase III criteria.  The 
PermaNet™ has an interim recommendation while the Olyset™ net has a full recommendation.  
The criteria are outlined at the following website:  
http://whqlibdoc.who.int/hq/2005/WHO_CDS_WHOPES_GCDPP_2005.11.pdf 
 
In order for the product to be used, the product should first be registered by the country.  The 
registration process will vary by country.  The national registration authority is responsible for 
ensuring that pesticide use conforms to national standards.  WHOPES recommendation will 
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often facilitate the country registration of a product and should minimize or eliminate the need 
for local product testing prior to registration. WHO specifications and pesticide quality 
standards are part of the International Code of Conduct on the Distribution and Use of 
Pesticides. WHO recommendations on the use of pesticides in public health are valid ONLY if 
linked to WHO specifications for their quality control. 
2.4. Prospects for new products 
Additional long lasting insecticidal products are being developed.  One approach being explored 
is the production of a long lasting yarn (with insecticide coated or incorporated) that can then 
be knitted into nets using existing machinery currently used to produce polyester nets.  A 
promising approach to LLINs is the prospect of a single-dose long-lasting insecticide treatment 
that can turn any net into a LLIN, and that can be applied in the field to a wide variety of 
fabrics.  Such a product will be especially important in countries with significant coverage 
levels of untreated nets.   For example in Mali, net coverage rates are more than 50% overall.  
Manufacturers of mosquito nets are also likely to be interested in this product with which they 
will have the option of converting their nets to LLINs at source before they reach the market. 
One product targeting polyester netting material has recently been submitted to WHOPES for 
testing and evaluation.   
 
When new products are ready for wide-scale field use, current concerns about supply 
constraints will be alleviated and reductions in procurement and costs would be expected.    
 
3. Delivery channels for covering the majority 
All pregnant women and children under five years will not be fully reached by any one public 
health delivery system/channel. Therefore a combination of systems is needed for ITN delivery 
in order to reach the full complement of malaria target groups.   In this section, the options for 
distributing ITNs are described which aim to “catch-up” (rapid scale-up), “keep-up” (maintain 
consistent availability of ITNs), and reach vulnerable groups in emergency situations.    
 
Distribution of adequate numbers of ITNs by itself is necessary but not sufficient, since 
provision will not immediately translate into correct and consistent use.  Comprehensive 
communication needs to accompany distribution systems.  While not all ITNs distributed for use 
by a child or pregnant woman are used by them, surveys across 6 countries5 consistently show 
that a greater proportion of children under five years old sleep under a net than other age-
groups.   Net use rates were also above average in women aged between 14 and 49 years, while 
adult men were the least likely sub-group to use nets.  
 
The terms ‘catch-up’ and ‘keep-up’ are borrowed from EPI; however, these terms have 
different implications for ITNs compared with childhood vaccines.  
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3.1 Catch-up 
As coverage across countries of sub-Saharan Africa (SSA) is currently low, a ‘catch-up’ period of 
rapid scale-up is suggested as a complement to a more sustained ‘keep-up’ set of strategies.  
Strategies suggested for a rapid scale-up are combined measles campaigns, national polio 
immunization days (NIDs), child health days/weeks and (re)treatment of nets currently in 
households. 
3.1.1 Combined measles campaigns 
The main target group for measles campaigns, known as Supplementary Immunization Activities 
(SIAs) is children 9 to 59 months, or in some cases children 9 months to 15 years. There are two 
categories of measles SIAs: catch-up campaigns and follow-up campaigns. Catch-up campaigns 
aim to vaccinate all children aged 9 months to 15 years, in order to reduce the number of 
susceptible persons in the population including both those who were never vaccinated and 
those in whom the primary vaccination failed. Follow-up campaigns target children 9 to 59 
months with the aim of reducing the number of susceptible persons born since the last SIA. 
Children below 9 months are therefore normally excluded from these campaigns.   Occasionally, 
if a significant proportion of measles cases occur in children between 6 and 9 months, usually in 
emergency or refugee populations, then this group may be included. A significant advantage of 
these campaigns is that they can be used as vehicles to rapidly deliver ITNs to large numbers of 
vulnerable people. It should be noted, however, that although such campaigns involve delivery 
over just a few days, the period of planning and preparation for distribution is necessarily 
extensive. Depending on the measles epidemiology and the performance of the routine EPI 
programme, these campaigns which may occur at 3 or 4-year intervals also have the important 
advantage that the resulting ITN coverage is equitable, reaching children who do not attend 
ANC or EPI services, who are often the poorest and most distant from health services.   
Catch-up  
EPI this term is used for campaigns where the aim is to vaccinate all children aged nine 
months to fifteen years in order to reduce the numbers of susceptible persons in the 
population (those never vaccinated and those in whom the primary vaccination failed). 
These campaigns need to interrupt transmission and therefore need to be conducted 
over a period of a few days. Routine systems are not used for ‘catch-up’ in EPI.  
ITNs The aim is to achieve a rapid increase in the proportion of pregnant women and 
children under five years who are sleeping under an ITN. There is not a need for this 
rapid increase to occur within just a few days. Routine systems can also be used to 
catch-up on coverage to deliver the intervention, and are necessary as campaigns do not 
cover the complete target group. Where resources are available delivery of ITNs through 
routine systems will initially need to cover the whole population of children up to five 
years, and all pregnant women, whereas in later maintenance phases those newly 
pregnant and under one year olds will be mainly targeted for delivery. This represents a 
‘catch-up’ phase.  
 
Keep-up 
EPI The aim is to maintain high coverage through routine activities during inter-campaign 
periods.  
ITNs the aim is to ensure that ITNs are available to all pregnant women and all children 
under five years at all times. Keep-up aims not only to maintain high levels of household 
ownership of ITNs but also to ensure that they are used regularly and in the most 
appropriate manner by the target group for maximum effectiveness. Where ITNs are not 
long-lasting this includes ensuring that nets are retreated.   
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This approach has a disadvantage in that coverage achieved in a campaign is complete only for 
the population present at the time of the campaign.  Children born after the campaign will not 
be protected for the first five years of their lives unless ITNs are available by additional routes, 
or they happen to share a sleeping place with an older sibling who received an ITN.  For 
example, if a campaign giving ITNs to all children under five is repeated every four years, then 
only 25% of children will be given a new ITN during their first year of life. The majority of 
children will be conceived and born and reach their first birthday during the inter-campaign 
interval, and will be given a net only when the period of greatest vulnerability to malaria is 
over.     
 
 
 
Compared to other delivery systems, therefore, campaigns are relatively good at achieving both 
socioeconomic and geographical equity (i.e. they reach the poor and remote communities), and 
they will often be the only way of reaching people in areas where routine services have broken 
down, due to conflict or disasters. On the other hand, campaigns are inefficient for achieving 
“timing equity”, as children born shortly before a campaign will enjoy far better health 
benefits than children born later in the in the inter-campaign interval. 
 
3.1. 2 (Re)treatment campaigns: converting conventional nets to ITNs 
According to the Africa Malaria Report 2, about 80% of the nets in household use in Africa are 
untreated, and the great majority of these nets are presumably purchased from local 
unsubsidized commercial sources.  Untreated nets in good condition offer approximately half as 
much protection as ITNs 6-12.   
 
In many African countries, untreated nets are relatively equitably distributed across socio-
economic groups, and in some places, poor rural households are more likely to have an 
untreated net than rich urban households. Almost everywhere, untreated nets are far more 
equitably distributed across socio-economic groups, than ITNs. So these untreated nets, and the 
systems that distribute them, have considerable public health value.  
 
This situation offers an important opportunity: by treating these nets with insecticide, through 
campaigns or other means, we could very rapidly bring about a massive increase in the number 
of ITNs in Africa. One advantage of this idea is that the insecticide is relatively cheap compared 
to the price of a net (US$ 0.35 versus US$ 2.50 at bulk prices); another is that there are no 
supply constraints on insecticide and prompt delivery can usually be arranged.  Retreatment 
campaigns in Cameroon and Uganda have demonstrated that campaigns can readily be 
organized, and can produce substantial and very rapid increases in ITN coverage13,14.  
 
Economic argument and experience also favour the policy of insecticide treatment free of 
charge. Modelling the cost-effectiveness of ITNs compared to insecticide treatment of existing 
nets found the range for ITNs of US$ 19-85 per Disability Adjusted Life Year (DALY) averted 
improved to US$ 4-10 if only insecticide was required15. The addition of the insecticide to an 
untreated net converts it from a private good into something that produces substantial external 
benefits for the community as a whole, and this gives theoretical justification to the idea that 
The health benefits of ITN coverage during the first two years of life will 
normally be far greater than those of coverage during the subsequent three 
years. Therefore, not all children under five years are equally at risk. The risk 
of malaria in Africa is strongly concentrated in the youngest children, and in 
many settings, half of all under five deaths happen in the first year of life.  
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the insecticide in particular should be publicly funded. In practice, moreover, programmes have 
found that treatment coverage levels fell dramatically when the insecticide started to be sold 
where previously it had been given free of charge 16.  
 
Treatment of existing nets can effectively be combined with the ITN and LLIN distribution 
discussed elsewhere in this document, including through campaigns. (Re)treatment will remain 
a necessary element in ITN distribution plans for at least as long as the supply of LLINs remain 
limited. The availability of products enabling the conversion of any kind of net to an LLIN in the 
field is imminent, and holds the promise of converting all nets to LLINs through treatment 
campaigns. 
3.1.3 National Immunization Days (NIDs) 
The eradication of polio is now a global public health goal, and NIDs are therefore a time-
limited intervention. Polio NIDs aim to interrupt poliovirus transmission through giving oral polio 
vaccine (OPV) to all children in a large geographic area over a short period of time. Therefore 
special efforts are needed to reach children who are missed by routine immunization services. 
During NIDs doses of OPV are given to children within a defined age group, which is usually 0 to 
59 months of age, regardless of their vaccination history. These are considered to be additional 
doses and do not replace those received through routine EPI. The aim is to provide these 
vaccinations during each round of NIDs in as short a period of time as possible, and preferably 
within two days. NIDs are conducted in two rounds and the second round should take place four 
to six weeks after the first. NIDs are expected to be conducted annually for 3 years after which 
time polio should be reduced to focal transmission and NIDs will be replaced by mopping-up 
campaigns and sub-national immunization days (SNIDs) as appropriate. 
 
Polio NIDs usually involve door-to-door vaccinations together with vaccinations within the 
community more generally. Every opportunity is taken to vaccinate a child. This has several 
implications for integrating delivery with ITNs. The first of which is the transportation of the 
heavy, bulky nets by volunteers. The second is that children are frequently vaccinated in the 
absence of an adult; this is a strategy which is not conducive with a policy of providing one ITN 
per caretaker and there is a broader question to be asked on giving the ITN directly to an 
unaccompanied child.  
 
The number of countries in which NIDs are conducted, and their frequency within countries, 
will decrease. There are eight countries in SSA planning NIDs in 2006. Although combined 
delivery of ITNs with NIDs was carried out in Central Region, Ghana, in October 2004, and again 
almost at a national scale in Niger in December 2005 (whole country except Niamey)there has 
been less focus on the delivery of ITN through NIDs than through measles campaigns.  
 
 
 
 
 
 
 
 
 
The best way to achieve universal coverage is to build universal provision through 
routine services (such as ANC and EPI), as the primary method of delivery, 
supported by delivery through extended outreach and community-based systems. 
Campaigns are very useful in the short-term for achieving rapid and equitable 
scale-up 
 
Donors considering investing in one or other of these systems are encouraged to 
give commitment to long-term support for routine services.   
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3.2 Keep-up 
In this section, delivery choices for maintaining constant access to ITNs are discussed. 
3.2.1 Antenatal clinics (ANC) and Expanded Programme on Immunization (EPI)  
ANCs offer a good opportunity for targeting pregnant women with the delivery of ITNs. The aim 
of delivering an ITN through this channel is that the recipient will use the ITN while pregnant 
and share the ITN with the newborn child for at least one year.  In this way, ANCs provide a 
delivery channel for ITNs to both pregnant women and young children during their most 
vulnerable period.  
  
Delivery of ITNs to children concurrent with EPI presents an opportunity for reaching children 
under one year. The proportion of children under one year reached with the various EPI 
vaccines is officially reported by countries to WHO/UNICEF in the annual joint reporting form 
and WHO/UNICEF estimates of immunization coverage are calculated on this basis.  DTP1 may 
be used as a proxy indicator of the proportion of children that attend any vaccination.  As 
measles is the final vaccination at 9 months of age, measles vaccination can be a proxy 
indicator of the proportion of children under one year who complete routine EPI.  
 
In addition to free distribution of ITNs through ANC/EPI, both ANC and EPI also provide ITNs 
through subsidies by: 1) giving a subsidized ITN (i.e., direct product) or 2) giving a discount 
voucher (of varying values including 100% discount) which can be exchanged for an ITN at a 
commercial or other pre-identified outlet.  In general the use of vouchers in the immediate 
term is more appropriate where commercial distribution is relatively well developed. The 
voucher system may, however, help promote a commercial market for ITNs and penetration of 
ITNs into more rural areas. Vouchers have the added advantage of avoiding the bulk storage 
facilities needed for continuous supply of ITNs to ANC and EPI, which may be a significant 
problem in more remote rural areas. Some countries, such as Zambia, have segmented delivery 
of ITNs through ANC using direct delivery in rural areas and vouchers in urban areas.  
 
ANC and EPI systems are equitable in terms of timing, that is, aside from stock-outs, ITNs 
should always be available to pregnant women and young children.  This contrasts with 
campaigns where if you enter the target age group just after a campaign you are excluded. 
Moreover, in much of Africa, ANC and EPI systems achieve high levels of coverage.  However, 
these services can be variable in service delivery, failing in some countries to reach the poorest 
families.  ANC and EPI can be especially weak in remote, sparsely populated areas with poor 
infrastructures.  They also tend to break down in conflict and emergency situations.  
 
There are differences between ANC and EPI-based delivery of ITNs.  ANC coverage tends to be 
slightly higher than EPI coverage (ANC: 26.8 – 98.8%, median 83.8%; DTP3: 20.3 – 88.4%, median 
63.8%)1 .  Provision of ITNs through ANC allows women to use the ITN during pregnancies, and 
the child to be protected by the ITN from birth.  Provision of ITNs through EPI loses the benefits 
of pregnancy coverage, but means that the ITN will remain intact until the child is a little 
older.  Nevertheless, the second contact at EPI provides an opportunity to deliver a new ITN, 
retreat an old net or replace a damaged ITN. In this way, the two systems should complement 
each other very well. 
 
                                            
1 Analysis by the authors of data from Demographic and Health Surveys (DHS) and Multiple Indicator 
Cluster Surveys (MICS) surveys across 29 countries 
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We expect a priori that the majority of those women who attend ANC are the same women who 
take their children for at least the initial EPI visits. In many countries (but not all) EPI coverage 
and ANC coverage varies together, that is, where one is low the other is also low.  This supports 
the hypothesis that most mothers either attend both ANC and EPI, or they attend neither, and 
only some attend one but not the other.  Data is needed on this association.  If ANC and EPI 
acted as independent systems in terms of who is reached, we would expect one system to reach 
most of the people missed by the other, and therefore delivering ITNs through both would 
greatly improve coverage. However, if the overlap between attendances through both of the 
systems is complete, then delivering ITNs through both systems would mean that those who 
attend get two ITNs and those who do not attend get none. Thus, depending on the strength of 
the association, the combination of ANC and EPI can help to produce much more equitable 
coverage, but in other conditions it can also reinforce existing differentials.  
 
Another point to consider is that delivery of ITNs through ANC and/or EPI may increase 
attendance. There is some evidence from the UNICEF supported Accelerated Child Survival and 
Development (ACSD) projects in Mali and Senegal that this is the case, with delivery of highly 
subsidized ITNs through ANC increasing attendance17.  
 
3.2.2 The commercial sector 
Surveys indicate that the majority of the nets currently in use in African households are 
untreated, and these were presumably delivered through the commercial sector18. The 
commercial sector includes manufacturers, importers, wholesalers, retailers, and various 
itinerant traders, working within the formal or informal commercial sectors. To date, public-
private partnerships in the delivery of ITNs have tended to focus on the formal private sector 
with distribution generally through factory-based manufacturers of mosquito nets and ITNs, 
distribution by agricultural and pharmaceutical distribution companies and retailing through 
relatively fixed and formal outlets such as pharmacies and petrol stations.  Many of these 
partnerships with the formal commercial sector have achieved better distribution of ITNs in 
urban areas than in rural areas.  
 
Partnerships with the informal private sector, including manufacturers of locally stitched 
mosquito nets and traders in open markets, have so far not been developed. These informal 
distribution systems, operating through very small businesses, provide the channels through 
which many goods, including clothes and textiles, are distributed into remote rural areas. They 
have been shown to be much better than more fixed and formal distribution systems at 
delivering nets to the poor in some countries, particularly those with longstanding net cultures 
and particularly in West Africa 5,18. 
  
Although the commercial sector does not specifically target pregnant women and children 
under five years, there is evidence that they have achieved good coverage of these groups with 
untreated nets in some countries.  Collated data from 11 household surveys, commissioned by 
NetMark in 8 countries5 www.netmark.org, shows that a substantially larger proportion of nets 
in households were delivered through the commercial sector than through non-commercial 
sources (Table 1).  
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Table 1: Proportion of nets in households delivered through commercial sources 
 
2000 2004  
Household 
ownership1 
Total 
number 
of nets 
recorded3 
% nets 
from a 
commercial 
source2 
Household 
ownership1 
Total 
number 
of nets 
recorded3 
% nets 
from a 
commercial 
source2 
Ethiopia    25.3 313 57.5 
Ghana    38.1 769 59.7 
Mali    72.84 1,2444 74.34 
Mozambique 26.5 403 78.8    
Nigeria 12.0 159 92.4 26.7 155 69.0 
Senegal 33.6 598 69.9 56.1 2,309 27.3 
Uganda 34.0 586 86.8    
Zambia 26.5 363 51.4 50.0 318 58.2 
MEDIAN 26.6 403 78.8 44.1 543.5 59.0 
 
1 Proportion of households with at least 1 mosquito net 
2 Includes: market, kiosk, street vendor, general shop, textile shop, wholesaler, pharmacy, drug store,  
  supermarket, mini-mart, hawker/moving kiosk, petrol station, tailor  
  Excludes: project, health facility, school, gift, employer, bought from relative/neighbour, don’t know 
3 Excludes missing responses 
4 2003 
 
In the more recent 2004 NetMark surveys, a median of 59% of nets were purchased from a 
commercial source (ranging from 27% in Senegal to 74% in Mali). This represents a decrease 
compared to the median of the 2000 surveys (79%), which is probably due to an increase in the 
rate of ITN output from NGO and government programmes, rather than a reduction in 
commercial sales.  
 
3.3. Delivery channels for the inaccessible and most disadvantaged 
While there are many gaps in our knowledge on the delivery of ITNs aimed at covering the 
majority populations through routine health systems, these gaps are relatively small in 
comparison with the problem of reaching the most remote and/or disadvantaged populations.   
Three strategies are now outlined for delivery of ITNs to the geographically dispersed and most 
socio-economically disadvantaged pregnant women and children under five years. 
3.3.1 EPI outreach 
EPI has developed strategies for addressing delivery of immunizations to populations in the 
most inaccessible geographic areas:  the Reaching Every District (RED) strategy and Global 
Immunization Vision and Strategy (GIVS). RED was the name given to a strategy of district 
capacity building with the aim of increasing immunization coverage, and has been adopted by 
many countries Africa since 2002. A recent evaluation found that coverage of DTP3 increased in 
4 of 5 countries where assessments were conducted19.  GIVS was developed by WHO and UNICEF 
and launched in 2005 at the World Health Assembly.  GIVS has three main aims: to immunize 
more people against more diseases; to introduce a range of newly available vaccines and 
technologies; and to provide a number of critical health interventions with immunization 
(www.who.int.vaccines/givs ). The focus on reaching geographically remote population through 
EPI outreach offers the possibility of increased coverage with ITNs by integration with delivery 
systems that have been strengthened through RED and GIVS strategies.         
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3.3.2 Community-based delivery 
Community-based delivery systems promote the expansion of health care systems within 
communities, independent of health professionals and for those out of reach of the health 
systems. Community-based systems are built on the principle that the most effective and 
efficient way to promote health care is to ensure that it is locally determined, and guided by a 
thorough knowledge of the needs of economically disadvantaged people. Community-based 
systems are particularly useful in areas with strong networks of trained community health 
workers or community-based organizations (CBOs) and well established non-governmental 
organizations (NGOs). 
 
3.3.3 Child Health Weeks (CHWs) 
CHWs can be used to intensify delivery of a minimum package of services together with health 
education on preventive care, to children aged 0 to 59 months. The goal of CHW is both to 
increase coverage with child survival interventions and to encourage increased use of routine 
services for these interventions by creating awareness and demand.  ITN delivery and education 
is consistent with CHW goals. 
 
CHWs (and Child Health Days) are not campaigns; they are ‘expanded routine’. They generally 
involve variable packages of child survival interventions such as EPI vaccines, Vitamin A 
supplementation, growth monitoring, and ITN (re)treatment. Other services have included 
education of caregivers on home management of fevers, promotion of use of iodized salts, 
awareness creation on HIV/AIDS and promotion of male and female condoms, family planning 
services, distribution of iron tablets, distribution of de-worming tablets and birth registration. A 
major difference between CHW and campaigns is that during campaigns children of the target 
age are vaccinated regardless of their immunization status whilst during CHW immunizations 
are conducted according to health cards. To-date CHWs have been used more for the delivery 
of (re)treatment than of ITNs, for example in Ghana and Zambia.  
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4. Scaling-up: estimates of the number of ITNs needed over the next five years  
The total number of ITNs needed for delivery to the target population for the next five years 
may be calculated using a number of different delivery system scenarios and assumptions. We 
calculated the target population, that is, total number of pregnant women and children under 
five years across 42 countries of sub-Saharan Africa.  We then estimated the number of ITNs 
needed over the next five years under three scenarios. In Scenario 1 we assume that 100% of 
the target population are fully covered for the full extent of the five years; under this scenario 
we do not specify delivery systems.  In Scenario 2 we estimate the number of ITNs needed if 
they are delivered to pregnant women through ANC and to children 9 to 59 months through 
planned2 measles campaigns (at the time of writing campaigns were planned between 2006 and 
2007). In Scenario 3 we estimate the number of ITNs needed if they are delivered to pregnant 
women through ANC, to children 9 to 59 months through measles campaigns, and to children 
under one through EPI. In Scenarios 2 and 3 we assume 100% attendance at ANC by pregnant 
women and at EPI by children under one year.   
4.1 Data sources 
All population data was derived from World Population Prospects Population Databases. Total 
populations and number of children under five years were taken directly from the 2002 
Revision20 database; numbers of children under one were taken from the 2004 Revision (Annex 2 
Table I).  Numbers of pregnant women were calculated from number of live births plus the 
number of maternal deaths during pregnancy 20. Figures used for the purpose of this report are 
                                            
2 campaigns planned as of August 2005. 
Summary of rationale 
 
The action plan presented is based upon: 
1) Universal and sustained provision ensuring that all children under five years 
and pregnant women have access to an ITN, and that this provision can be 
sustained in the long-term.  
2) Catch-up aimed at accelerated scale-up of coverage through integrated 
immunization campaigns and (re)treatment of the nets currently in households.  
3) Keep-up of coverage through routine systems (ANC and EPI) which are 
emphasized as the primary method for longer term delivery of ITNs to target 
groups. These are supported by outreach services and community-based 
distribution. 
4) Covering the majority through both ANC and EPI, thus effectively delivering 
two ITNs per household. Where funds are sufficient for one ITN only, children 
under one year and therefore ANC should be prioritized over children 1-4 years 
and EPI.  
5) Reaching the minority who are out of reach of routine health services 
through outreach and community-based systems.  Accessing this minority of 
pregnant women and children under one year is a priority.  
6) Special situations exist in countries with very weak health systems such as 
those with a history of complex emergencies. In these countries, campaigns may 
be the best way to achieve and maintain coverage.  
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population projections for 2004, except for costing estimates which used projections for the 
years 2006-2010 (courtesy of John Miller, WHO).  
 
Estimates of populations living in areas at risk of malaria transmission were calculated from the 
Mapping Malaria Risk in Africa project21, multiplying target population figures by the percentage 
at any risk of malaria transmission (i.e. epidemic and endemic). 
4.2. The target group  
The total population in 42 countries of sub-Saharan Africa living at risk of malaria, including 
both endemic and epidemic areas, is almost 615 million (Annex Table I). Of these living at risk 
of malaria, around one fifth can be classified as biologically ‘vulnerable’, including 109.7 
million children under five years and 25.6 million pregnant women. Total numbers of at risk 
vulnerable populations vary greatly between individual countries, with Nigeria alone accounting 
for 20% of those living in the 42 endemic countries. 
4.3 100% of target groups covered within the first year and coverage maintained for five 
years (delivery system unspecified) 
We can make initial calculations of the number of nets needed to meet and maintain 100% 
coverage of the target group of pregnant women and children under five where no delivery 
channel or mix of channels are specified. These calculations are based on the population 
estimates of these groups by year.  For the first year (2006) numbers will be equivalent to the 
total population estimates of these groups; for subsequent years 100% coverage will be 
maintained by giving one ITN to every pregnant woman (the new cohort of children one year old 
will be covered by the nets of their mothers received during pregnancy).  Assuming that each 
ITN lasts exactly 3 years, then for each year from 2009, it would also be necessary to provide 
new ITNs to those still under five and no longer covered (in addition to covering pregnant 
women).  In 2006 this is equal to 135.3m ITNs followed by 26.2m-71.4m ITNs during subsequent 
years (Annex Table II). The assumption here is that we will be able to deliver this number of 
ITNs to the target population within the first year of resources becoming available and to then 
continue at the same scale.  Using this scenario 312.3m ITNs are needed over the next five 
years (Table 2).  
 
Table 2: Estimated number of ITNs needed and their costs assuming 100% attendance at ANC and EPI 
 
 No. NETS NEEDED COST (at US$7.28/ITN) 
 
YEAR SCENARIO 1 
100% coverage 
of vulnerable 
population 
SCENARIO 2 
ANC & measles 
campaigns 
SCENARIO 3 
ANC, EPI & 
measles 
campaigns 
SCENARIO 1 
100% coverage 
of vulnerable 
population 
SCENARIO 2 
ANC & measles 
campaigns 
SCENARIO 3 
ANC, EPI & 
measles 
campaigns 
2006 135,262,874 69,515,656 79,932,941 984,713,723 506,073,974 581,911,813 
 
2007 26,205,756 33,581,586 44,170,023 190,777,904 244,473,946 321,557,766 
 
2008 26,840,334 26,840,334 37,594,960 195,397,632 195,397,632 273,691,307 
 
2009 71,356,796 27,483,724 38,398,303 519,477,478 200,081,511 279,539,649 
 
2010 52,591,156 28,135,957 39,202,769 382,863,616 204,829,767 285,396,158 
 
TOTAL 312,256,916 185,557,257 239,298,996 2,273,230,351 1,350,856,829 1,742,096,692 
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4.4 Delivery through ANC and measles campaigns, assuming 100% attendance 
If ITNs are delivered to all pregnant women through routine ANC, assuming that 100% of 
pregnant women attend ANC and that they will all be given one ITN when they do so then 
25.6m–28.1m ITNs are needed every year (accounting for increases in projected populations of 
pregnant women – Annex 2 Table II).  
 
Using available information on planned measles campaigns during 2006 and 2007 and assuming 
that delivery of ITNs could be combined in all of the campaigns to all children under five we 
calculate that 53.3m ITNs could be delivered during 2006 and 9.4m during 2007. This includes 
delivery of ITNs in 26 countries scheduled for measles campaigns in 2006-2007. Thus, across the 
42 countries 62.8m ITNs could be delivered. (Annex Table III). 
 
The total number of ITNs delivered using both ANC (assuming 100% coverage) and planned 
measles campaigns would then be 197.0m over 2006-2010 (Table 2). 
4.5 Delivery through ANC, EPI and measles campaigns, assuming 100% attendance 
If we add delivery of an extra ITN through EPI vaccination (children aged 9 months), again 
assuming 100% national measles coverage, we dramatically increase the number of ITNs needed 
from 197.0m to 316.4m over 2006-2010 (Table 2).  
5. Costs of reaching 100% coverage of target groups  
Estimating the costs of scaling-up coverage with ITNs to 100% of target groups is a complex 
challenge which can be approached from a number of perspectives. We review previous 
estimates and discuss the limited evidence upon which further estimates may be based.  
5.1 Review of previous estimates of the cost of scaling-up ITN coverage in Africa 
A number of recent estimates of the number of ITNs needed to meet the Abuja and/or MDG 
targets have been made, and some of these have included estimates of the expected costs. 
Although it is difficult to compare these studies since they all had slightly different objectives 
and methods, three of the most prominent reports are summarized below (see also Annex 2 
Table IV): 
 
1) Miller et al 22 calculate that between 92.3m-169.3m ITNs are needed to reach the Abuja 
60% coverage of pregnant women and children under five by 2005.  Using a highly 
conservative cost per net of US$ 2.80, this equates to a funding need of US$ 258m-
474m.  
2) Kiszewski et al 23 have the more ambitious objective of calculating the costs needed to 
support the basic malaria control interventions for the achievement of the 2010 RBM and 
WHO targets of minimum 80% coverage and 2015 malaria MDG.  For ITN coverage in 
Africa alone, based on distribution of LLINs, this is estimated to require a total of US$ 
1.6b over the next 10 years.  
3) A detailed national plan for scaled-up malaria control in Ethiopia 24 estimates that to 
reach and maintain 100% ITN coverage of the vulnerable target population (cumulative 
76.9m over 10 years) to 2015 will cost US$ 274m.  
 
On a smaller scale, several studies have estimated the cost per ITN delivered, and these 
estimates have varied widely, this is not surprising as they have worked at different scales, 
used different delivery channels and worked within different contexts. The one study that has 
provided cost per ITN delivered at national scale was for a programme which scaled-up from 
one district to the national level over a period of five years and delivered 83,353 to 951,789 per 
year25. However, the design of some of these studies makes comparisons difficult. They have 
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used different perspectives for the costing exercise - including costs to the provider only, or 
costs to users, the community and the provider. Some studies have focussed on financial costs, 
others on economic costs, or both financial and economic. Some have involved costs to the 
point of delivery only, while only a few included delivery to the end-user. Studies taking place 
during different time periods and using different products also make comparisons difficult as 
the costs of ITNs (and different types of these) fluctuate on the international market.  
 
Economic evaluation is based upon the balance between costs and consequences.  Here we are 
concerned with the costs in terms of increasing coverage. It is sometimes assumed that 
economies of scale can be taken for granted, that is, that unit costs can be expected to decline 
as scale increases. This is not necessarily so.  Scaling-up may reduce the unit costs in more 
densely populated, homogenous and accessible areas, but operational costs of reaching the 
distant, smaller communities are likely to be higher. Diseconomies of scale are therefore also 
likely. This adds considerably to the uncertainties inherent in the estimates discussed here. 
 
There is a lack of evidence within the health sector as a whole on the costs of scaling-up 
interventions: a recent review found only three studies containing cost data from programmes 
in the health sector that had already scaled-up26. Where average costs vary depending on scale 
(i.e., where there are economies and/or diseconomies of scale) it is misleading to transfer cost 
data from a smaller to a larger programme or vice versa 27.  We need to take account of the 
spatial aspects of scaling-up.  Broad areas where economies or diseconomies of scale exist in 
delivering health interventions include: geography and transportation; fixed costs of 
establishing a health infrastructure; human resources; and management transition costs27.  A 
study on the costs and effects of an ITN programme in Malawi 25 showed economies of scale as 
the programme scaled-up from district to national level, with the cost per ITN delivered 
decreasing from US$5.04 to US$1.92.  
 
Scaling-up may realize economies of scope by piggy-backing on current under-utilized capacity. 
It therefore follows that the cost of adding an intervention where there is an already 
established system and where there is unused capacity will be much less than where a system 
has to be expanded or newly established. It is unclear whether in those countries with lower 
ANC/EPI coverage this is due to an existing system being under-utilized or whether there is a 
breakdown in the system itself.  
 
As already noted, the initial estimates make very simplistic assumptions about costs, and are 
therefore approximate and subject to change as scaling-up proceeds.  Future efforts to develop 
more realistic estimates should consider the four factors which Johns et al26 suggested for 
inclusion in calculations of the cost of scaling-up interventions: 
1) Calculate separate unit costs for urban and rural populations;  
2) Identify economies and diseconomies of scale, and separate the fixed and variable 
components of the costs;  
3) Assess availability and capacity of health human resources;  
4) Include administrative costs, which can constitute a significant proportion of scale-up costs 
in the short run.   
5.2 A simplistic method for defining cost per ITN delivered 
In addition to the purchase price of the ITN itself, there are many operational and 
administrative costs involved in the various elements of delivery, including all transport, 
storage and human resource costs. Other operational costs include promotion, training, 
supervision, monitoring and evaluation. In order to calculate costs of providing the number of 
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ITNs needed, we have assumed a single universal ‘cost per ITN’ figure ignoring the fact that 
costs are likely to vary widely including over time.  
 
Various estimates of delivery costs are suggested by the costing studies mentioned above.  For 
example, Miller et al22 use the figure of US$ 1.00 per ITN, based on figures from a rural Kenyan 
ITN programme28 which includes wages, allowances, administration and four wheel drive 
transportation.  No promotional, training or M&E costs are included. The Ethiopia estimates24 
use US$ 2.00 per ITN to include handling, storage and distribution. Costs of IEC materials, staff 
training and M&E are estimated in separate detailed calculations and not given on a ‘per ITN’ 
basis. 
 
Thus, as outlined above we have published data on the cost of delivering ITNs at the national 
scale in one country only 25.  In order to try to quantify a realistic ‘cost per ITN’ for our 
calculations, detailed cost breakdowns for a number of smaller-scale ITN distributions were 
therefore also consulted (Table 3).  We also have preliminary data from the economic analysis 
of the combined measles campaign in Togo.  The Togo cost data is not yet published and the 
data cannot therefore be presented in Table 3.  The cost per net delivered including the cost of 
the ITN itself was US$5.97, and the cost of the delivery alone was US$1.64 29 in Togo.  The 
median cost for delivering an ITN across these six studies was US$2.73. 
 
Table 3: Cost calculations for individual programmes 
 Kenya 130 Kenya 2 31 Tanzania 32 Ghana 33 Malawi 25 
 
Delivery channel  ANC Employer/ 
community 
based 
Social 
marketing 
Measles 
campaign 
ANC/social 
marketing 
Scale  35 districts 2 regions 2 districts 1 district national 
       
Capital costs ITNs* 5,040,000 281,047 151,906 49,400 2,147,400 
 Vehicles  76,723 10,703  50,228 
 Furniture/ 
equipment 
 10,256 6,100  15,468 
Recurring costs Insecticide   33,033  191,555 
 Delivery to country 151,920   1,745  
 Delivery to district 143,424     
 Delivery to 
facilities 
172,800     
 Fuel/ maintenance  10,009   339,346 
       
 Brand creation   5,164  146,801 
 Sensitisation 70,000 27,937  450  
 IEC materials 80,784  33,658  272,646 
 M&E 100,000 12,190    
       
 Staff 0 283,731 165,674 0 357,204 
 Training  31,645  2,355  
 Office expenses  28,608   45,672 
 Supplies      
 Other   192,492   
       
 TOTAL 5,758,928 730,943 598,729 53,950 3,878,287 
 
Number of ITNs delivered 70,000˘ 39,131 65,111 14,600 1,471,941 
 
Cost per ITN delivered in 
US$(including the net) 
[7.31] [15.8] 9.19 [3.74] 2.63 
Cost per ITN delivered in US$ 
(excluding the net)  
[3.81]˘ [11.50] 6.86∂ 
 
[0.32]^ 
 
1.18 
* cost of pre-treated ITNs, or cost of mosquito net + insecticide 
˘ delivered to district level and financial 
[  ] = financial costs  
^ incremental only, all joint measles and ITN costs are apportioned to measles 
∂ authors calculations 
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We then estimated the cost of an ITN from the average of family-sized Olyset ® and PermaNet 
® listed on the RBM website. The average was US$ 4.55 per LLIN.  If we then assume that the 
cost for each LLIN delivered is the average cost of a LLIN plus the median cost of delivering a 
net, then the cost for each LLIN delivered is US$ 4.55 + US$ 2.73 = USD$ 7.28.  
5.3 Cost estimate for 100% of target groups covered within the first year and coverage 
maintained for five years (delivery system unspecified) 
The simplest calculation of cost is to take this cost per LLIN delivered and multiply by the 
target population estimates for each year. Using our calculations of number of ITNs required by 
this approach (312.3m over 2006-2010) and a cost of US$ 7.28 per ITN, this amounts to a total 
of US$ 2.27 billion for the five year period 2006-2010.  
5.4 Cost estimate for delivery through ANC and measles campaigns, assuming 100% 
attendance  
If the delivery strategy of ANC and measles campaigns is employed, this requires an estimated 
185.6m ITNs, costing US$ 1.3 billion or an average of US$260m per year. 
5.5 Cost estimate for delivery through ANC, EPI and measles campaigns, assuming 100% 
attendance 
If the delivery strategy of ANC, EPI and combined measles campaigns is employed, this requires 
an estimated 239.3m ITNs, costing US$ 1.74 billion for the same period.  
 
5.6 (Re) treatment campaigns 
Considering these calculations of ITN numbers needed to cover the target population over the 
next five years alone and the current manufacturing capacity of the two companies producing 
LLINs (projected at a maximum of 50m per year by the end of 2005), conventional ITNs still 
have an important role to play. (Re) treating the nets currently in households is one way in 
which to achieve rapid scale-up with ITNs.  Miller et al22 estimated the number of nets currently 
in households in Africa to be around 28.1 million, with around 4.7 million of these being ITNs.  
A rough estimate for the costs of retreating all of these existing nets can be made using the 
value of US$ 1 per net for the insecticide 34. This amounts to US$ 28.1 million per year.  Over 
five years the cost of (re)treating the estimated 28.1 million mosquito nets in households in 
Africa will therefore be US$ 140.5 million.  
 
6. Current coverage with interventions and access to delivery systems by the target 
groups 
Estimates of the number of ITNs needed to cover the target population and the costs of 
procuring and delivering these ITNs were made above, assuming that ANC, EPI and measles 
campaigns cover 100% of their target groups. That is, we assumed that all amongst the target 
groups may be reached through these channels. However, target groups not met through these 
channels are likely to be the most vulnerable amongst the population and finding ways to reach 
out to them should be a priority.  
 
We can use existing ANC and EPI coverage data to estimate what numbers and proportions of 
the targets are likely to receive ITNs through these systems and therefore those excluded, 
assuming that these systems are independent of each other. This then provides an estimate of 
the numbers and proportions who need to receive ITNs through alternative systems such as 
extended EPI outreach, community-based distribution and CHWs.  
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6.1 Data sources 
The principal sources of data on ANC attendance, coverage levels of mosquito nets, ITNs, and 
EPI vaccinations were the nationally-representative Multiple Indicator Cluster Surveys (MICS)35 
and the Demographic and Health Surveys (DHS)36.  National estimates of DTP1 and DTP3 were 
also provided by WHO/UNICEF (section 6.6). Twenty MICS surveys were available with data 
collected between1999-2001; 28 DHS surveys were consulted with study years ranging from 
1994 to 2004. Those older than available MICS surveys, however, were only used in the absence 
of any other data (as was often the case for ANC attendance). In the absence of MICS or DHS 
data: mosquito net/ITN coverage figures for Ethiopia and Mali were taken from NetMark surveys 
(not nationally-representative), and for Malawi from a national MoH malaria study37; ANC 
attendance was taken from a recent WHO/UNICEF antenatal care report 38. Other missing 
figures were estimated using median values from those countries where data was available. 
 
The possibility that ANC and EPI reach and fail to reach the same target sub-groups is discussed 
in section 3.1.1, together with the consequences of this association. For present purposes, we 
have avoided these questions by estimating only the expected number of contacts given 
existing coverage rates of each channel, and from this the total number of ITNs that would be 
given away, if one ITN is given at each contact. 
 
6.2 Delivery through ANC and measles campaigns, at current coverage estimates, with or 
without EPI 
Table 4 takes the figures calculated in Table 2 (above) and adjusts them to take account of 
available coverage data.  As before the first column represents the number of ITNs needed for 
100% coverage of the target groups. The second column presents the numbers actually 
expected to be distributed given actual ANC attendance rates from survey data (adjusted for 
population growth), and the measles campaigns planned for 2006-7.  Note, the campaigns are 
assumed to achieve 100% coverage of children under five in the countries where they occur, but 
no supplementary distributions to replace worn out nets for older children are included.  
 
Table 4: Estimated number of ITNs that could be delivered through existing systems at current and 
planned coverage levels 
 
 No. NETS COULD BE DELIVERED % COVERAGE OF VULNERABLE 
POPULATIONS 
 
YEAR 100% coverage 
of vulnerable 
population 
ANC & measles 
campaigns 
ANC, EPI & 
measles 
campaigns 
100% coverage 
of vulnerable 
population 
ANC & measles 
campaigns 
ANC, EPI & 
measles 
campaigns 
2006 135,262,874 61,218,509 71,635,794 100.0 52.2 59.9 
 
2007 26,205,756 25,067,969 35,656,406 100.0 63.2 78.5 
 
2008 26,840,334 18,107,270 28,861,896 100.0 53.8 76.5 
 
2009 71,356,796 18,528,002 29,442,581 100.0 29.7 52.3 
 
2010 52,591,156 18,954,185 30,020,997 100.0 25.9 48.5 
 
TOTAL 312,256,916 141,875,935 195,617,674 100.0   
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If ITNs are delivered to pregnant women through ANC (assuming that the most recent national 
coverage figures remain constant over the next five years), then 70.6m ITNs will be delivered 
over the five year period varying from 18.1-27.1m ITNs per year (accounting for increases in 
projected populations of pregnant women). The total number of ITNs delivered using both ANC 
coverage and planned measles campaigns (assuming these achieve 100% target coverage) would 
then be 178.2m over 2006-2010. 
 
If there is additional delivery of an extra ITN through DTP1, DTP3 or EPI measles vaccination, 
again assuming most recent national measles coverage remains constant, we dramatically 
increase the number of ITNs delivered from 178.2m to 297.6m over 2006-2010.  
 
This is a substantial increase, but is nevertheless still much smaller than the 312.3m over five 
years needed, according to Table 2, to cover 100% of children under five and 100% of pregnant 
women. It is important to observe from Table 4 that 100% of the target population will not be 
covered through routine systems alone (see also Annex 2 Tables V & VI). Outreach, community-
based delivery and other strategies are needed to achieve full coverage and as such the figure 
of 312.3m ITNs represents the true need if 100% of the target population are to be covered 
(delivery system unspecified).  
 
There is evidence (section 3.1.1) that delivery of ITNs through routine ANC and EPI services may 
increase attendance, thereby creating a positive impact upon not only ITN coverage, but also 
on the coverage of other maternal and child interventions.  In order to estimate numbers of 
ITNs that may be delivered through ANC we have used current coverage levels. If coverage was 
to increase then the number of ITNs delivered through these channels would increase 
correspondingly.   
 
6.3 Combined measles campaigns 
Combined delivery through measles campaigns is useful as a rapid scale-up and achieves 
relatively equitable, but not universal coverage.  We currently have data on ITN ownership 
among households with children under five years immediately following combined measles 
campaigns in three countries: 89.5%3 in one district of Ghana33, 86.9% across 5 districts of 
Zambia39 and 62.5% at the national level in Togo 40. These findings offer an indication that the 
achievements through this method of delivery may decrease with increasing scale.  Although in 
all these campaigns, coverage was surprisingly equitable across socio-economic quintiles (equity 
ratios of 0.92, 0.88 rural 1.19 urban, and 1.02 in Ghana, Zambia and Togo respectively). 
However, as already explained, the completeness of coverage is only temporary. Occasional 
campaigns are likely to be inequitable between children born in different years: those born just 
before a campaign will gain substantially more benefit than those born just after it, and this 
timing is important because the risk of malaria is highly concentrated in the youngest children.  
 
All but five (Comoros, Guinea-Bissau, Madagascar, Mali, and Togo) of the 42 sub-Saharan 
countries included in this study report planned measles campaigns between 2005 and 2008 
(Annex 2 Table III). Plans are already in development for combining delivery of ITNs in 11 of 
these countries.  
6.4 Antenatal clinics 
The proportion of pregnant women who attend ANC at least once during a pregnancy varies 
across countries from 21.1% in Sudan (southern) to 94.4% in Malawi (Annex 2 Table VII). The 
                                            
3 Proportion of caretakers who reported they had received an ITN during the campaign, rather than the 
proportion of households who own at least one net. 
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impact of distribution through ANC on equity of coverage depends upon the socio-economic 
status of those attending ANC, and possibly upon the cost of the ITN, for example, whether it is 
free or subsidized. The ratio of attendance in the poorest compared to the least poor socio-
economic groups varies between 0.17 in Chad to 0.92 in Kenya with a mean of 0.66 across the 
21 countries for which we were able to access data. Coverage in the poorest quintile varies 
between 12.0% in Chad to 91.0% in Zambia, with a median of 67.0% across the 21 countries.  
6.5 Expanded Programme on Immunization (EPI)  
Using survey data, the national average for proportion of children one year old covered with 
DTP1 (by immunization card or mothers report) varies from 42.6% in Nigeria to 95.9% in Malawi 
(Annex 2 Table VII). The national average for proportion of children one year old covered with 
DTP3 (by immunization card or mothers report) varies from 20.7% in Ethiopia to 85.9% in the 
United Republic of Tanzania (Annex 2 Table VII). Using the most recent WHO/UNICEF estimates4 
from 2004 (Annex 2 Table VII), the national DTP1 coverage across countries at risk of endemic 
or epidemic malaria in Africa ranges from 43% in Nigeria to 99.0% in Benin and Burkina Faso.  
Estimates of DTP3 coverage are typically lower than DTP1 (indicating drop-outs) and range from 
25% in Nigeria to 95% in the United Republic of Tanzania.  
 
Coverage of childhood vaccinations varies not only between countries but within countries with 
some provinces having relatively high coverage and others relatively low. At the district level 
ranges may be even wider. Surveys indicate that Nigeria has one of the wider variations in 
coverage of DTP1 by province (20.0% to 83.7%; median 64.2%), and the variation is even wider 
for DTP3 (5.8% to 67.8%; median 28.2%). This contrasts with Burundi where coverage of DTP1 
ranges between only 83.8% to 89.7%; median 85.7% and DTP3 71.6% to 79.8%, median 75%.  
 
Equity of coverage with EPI across socio-economic quintiles increases with increasing 
coverage18: countries with higher coverage also have more equitable coverage. The strong 
socio-economic differentials seen in some countries may be largely a reflection of geographic 
differences in access to services. The ratio of attendance (using DTP1 coverage) in the poorest 
compared to the least poor socio-economic groups varies from 0.25 in Nigeria to 1.00 in Rwanda 
with a mean of 0.73 across the 24 countries where data was available. Coverage of DTP1 in the 
poorest quintile varies between 21.9% in Nigeria to 92.6% in Swaziland, with a median of 68.5% 
across the 24 countries. DTP3 coverage in the poorest quintile varies between 7.1% in Nigeria to 
81.5% in Eritrea, with a median of 45.3% across the 24 countries. 
 
It is clear from the above that both geographic and socio-economic inequities need addressing 
in delivering ITNs through the systems we are proposing. The scale of these inequities, and 
therefore the emphasis needed on outreach and other systems to reach the minority, varies 
accordingly.  
7. Current funding levels 
From information available from GFATM and DFID, a total of US$ 989m has so far been allocated 
to malaria control, rising to US$ 1.44b when accounting for GFATM maximum five year funds 
(see Annex 2 Table VIII).  Mosquito nets are increasingly becoming a central component of most 
funded national malaria control programmes with a total of almost 19m nets having been sold 
or distributed since 2000 (see Annex 2 Table IX; WMR 2005).  
                                            
4 Based on data reported to WHO and UNICEF by national authorities and immunization coverage surveys, 
consideration of potential biases, and contributions from local experts, WHO and UNICEF annually 
provide and publish official estimates of the most likely true levels of immunization coverage.    
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However, as the calculations in this report and elsewhere show, to deliver ITNs to the full 
target groups through routine ANC and EPI and complementary catch-up with combined measles 
campaigns 316.4m ITNs are needed costing an estimated US$ 2.50 billion over the next 5 years.  
8. Relative costs of different distribution strategies 
We have used a single estimate for delivery of ITNs which is not based upon specific delivery 
channels; the reason for this is that there simply is no data upon which to base more refined 
estimates. These delivery costs may be over-estimates for some of the routine services and 
campaign delivery that are a) open to economies of scale and b) piggy-backing onto established 
services. The priority emphasized throughout this document is to provide ITNs to all children 
under five years and pregnant women living in areas at risk of malaria in Africa.  It has been 
shown with EPI programmes that the cost per vaccine delivered increases where high levels of 
population coverage are achieved 41,42. It is likely that reaching out to the geographically and 
economically disadvantaged is a major factor in this increased cost. Therefore, whilst possibly 
being over-estimates for covering the majority, our delivery costs should allow for the priority 
of reaching the most vulnerable.  
9. Mix of strategies for different country infrastructures 
A complex variety of factors influences the most appropriate set of delivery channels for ITNs 
at the country level. These are best assessed country-by-country.  However, in order to provide 
a simplified guide to selecting between the major channels of delivery outlined in this 
document we have constructed a decision matrix.  
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Figure 1: ITN campaign delivery decision matrix based upon assumed constant delivery 
through ANC/EPI including outreach systems 
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The matrix is based on the assumption that: 
a) for all countries, whatever their context, establishing delivery of ITNs through ANC, EPI 
and outreach systems is a priority; this is the rationale of the action plan as a whole 
b) current ANC attendance will then determine the priority to be given to delivery of ITNs 
through vaccination campaigns, where ANC attendance is high the need for campaigns is low, 
and where attendance is low the need for campaigns is high  
c) coverage with mosquito nets will determine the relative usefulness of (re) treatment 
campaigns  
 
This means that for those countries within the >80% ANC attendance (for example the United 
Republic of Tanzania with 94% ANC attendance Annex 2 Table VII), national level combined 
campaigns are not likely to be a priority once delivery through routine systems is established. 
However, in countries where ANC attendance is low (<60%), combined campaigns will be an 
important delivery strategy until ANC attendance increases. Note that the interpretation of the 
table must be influenced by further experience in whether regular reliable provision of ITNs 
through ANC increases ANC attendance rates. The caveat to this matrix is that these decisions 
need to be made at the district level as coverage of ANC varies greatly from district to district 
and national level data often hides wide disparities.  
 
The impact of (re)treatment campaigns on coverage with ITNs is directly dependent upon the 
current coverage levels5, and will increase with increasing coverage. Currently whilst the 
majority of the nets in households are either untreated or conventional ITNs estimates may 
simply be taken from the coverage of any net.  However, as the proportion of LLINs in 
households relative to other nets increases this should be included in the equation.  
 
As an example, we place countries in position in the matrix (Figure 2) dependent upon their 
current ANC attendance and coverage with mosquito nets. Their position in the matrix will 
indicate the most appropriate mix of delivery strategies, again assuming that ITNs are delivered 
through ANC as a priority. This matrix is not designed to be prescriptive, but is designed to be 
fluid with countries moving between the sections of the matrix as their ANC attendance and net 
                                            
5 We use household ownership rather than use in children under five years  
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coverage changes. The optimum mix of delivery strategies will vary accordingly. It is interesting 
to note that the countries with the largest populations that are Nigeria, DRC and Ethiopia are 
the least advantaged in terms of both attendance at ANC and current mosquito net coverage. 
 
 
Figure 2: Country positions in the ITN delivery channel decision matrix  
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These tools should be used at the national level with districts being placed into the matrix, in 
the same way as countries in our example, so that a picture of priority needs across the country 
can be easily identified.   
10. Monitoring methods and systems 
We present a preliminary overview of the major indicators and methods for monitoring the 
successes of scale-up strategies and the processes by which they are implemented. At this stage 
we concentrate on monitoring of achievements at the outcome level. Indicators and detailed 
methods for outputs through each delivery channel will be presented as plans are taken to the 
next stage of development. 
 
10.1 Outcome Indicators 
Priority coverage indicators for household surveys have been recommended by RBM and form 
the basis of the Abuja targets1 (Table 5). These three priority indicators are “the proportion of 
households with at least one ITN”; “the proportion of children under five years who slept under 
an ITN the night before the survey”; and “the proportion of pregnant women who slept under 
an ITN the night before the survey”.  The use of standard indicators and methods allows for 
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comparisons of achievement within different countries and different contexts. Where indicators 
or methods are non-standard these comparisons are not possible. It is important that the 
operational definition of the indicator is stated in explicit detail, as this may vary even when 
the stated indicator has the same name. For example, there were problems in equating the 
successes of the combined measles campaigns in Ghana and Zambia when use was assessed 
amongst index children in a household33 rather than amongst the general population of 
children, thereby using a different denominator. 
 
Many coverage surveys give surprisingly little attention to information on the source of nets and 
ITNs, although this information is often quite easy to collect, and is of great value in indicating 
which delivery systems are reaching (and failing to reach) which groups of people. 
 
Current coverage of ITNs and untreated nets varies widely both across regions/provinces and 
across socio-economic groups. Achievements towards reducing the inequity of coverage need to 
be assessed. The simplest way in which this can be done is to present (disaggregate) the above 
indicators across geographic regions and across socio-economic groups and by delivery system.  
 
Table 5: Outcome indicators, denominators and levels of disaggregate 
Indicator Denominator Disaggregate 
 
1. Proportion of households with at least one 
ITN 
Number of all households 
sampled 
2. Proportion of children under five years who 
slept under an ITN the night before the survey 
Total number of children 
under five years in the 
sample 
3. Proportion of pregnant women who slept 
under an ITN the night before the survey 
Total number of pregnant 
women in the sample 
4. Proportion of nets that are untreated, 
conventional ITNs and LLINs 
Total number of nets in the 
sample 
Province/region 
Urban/rural 
Socio-economic quintile 
Delivery channel 
Net type 
 
Only one study in the United Republic of Tanzania has assessed the relative successes of more 
than one delivery strategy for ITNs in the same area at the same time43. Other studies have 
generally taken baseline coverage of ITNs and then compared this with post-implementation 
coverage after various time periods and assumed that any changes in coverage are due to their 
selected implementation strategy.  It should now be a priority to adapt household surveys so 
that they are able to provide data on the relative proportions of coverage that were achieved 
through different delivery channels. This has recently been found to be possible by the addition 
of one question on the source from which the ITN/net was obtained, together with careful 
planning of response categories adapted to delivery strategies in place nationally44. 
 
Identification of the types of nets/ITNs present in households is important for strategic 
planning. The use of (re)treatment campaigns as a method of increasing and sustaining ITN 
coverage is outlined above. If 100% of the nets in households are LLINs there is no added value 
from a (re)treatment campaign.  It is necessary therefore to know of the nets in households the 
proportions that are untreated, conventional ITNs and LLINs. Identifying the type of net may 
also provide insights into the delivery system that provides ITNs to the household.  
 
10.2 Methods for measuring outcomes 
The outcome indicators presented above are measured through household surveys. These are 
usually the DHS36 and MICS35 that are conducted about once every five years, or they may be 
special surveys conducted on an ad hoc basis such as the NetMark surveys5 and the RBM baseline 
surveys. Several MICS are underway in 2005 and it is not yet clear when there will be a further 
round of these surveys.  DHS are planned in 10 out of the 42 countries between 2006 and 2008. 
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This leaves 32 countries without planned surveys for assessing ITN coverage. The Malaria 
Indicator Surveys (MIS) have recently been developed by the RBM Partnership Monitoring and 
Evaluation Reference Group (MERG) to provide a standard package of tools for stand alone 
malaria surveys. These may provide data on ITN coverage but plans for country implementation 
of the surveys are not yet formulated. In order to assess the scale-up of delivery of ITNs to 
target groups it is essential that plans are formulated for national household surveys at least 
every two years.  
 
Disaggregates of coverage by province/region and urban rural area are provided in the national 
household surveys presented above. These surveys do not provide data on administrative levels 
below that of province/region.  Ideally we would like to have this data at the district level as 
there may be significant inequities in coverage within provinces and between districts. This 
level of data would be available through EPI cluster surveys, assuming that ITN questions were 
added to these surveys. This has been done in Timor Leste (nets not ITNs) and more recently in 
Ghana. There are lessons to be learnt from each of these experiences and some of the possible 
problems were outlined. But these surveys provide a promising way forward for expanding the 
number of surveys from which data on ITN coverage is available together with providing data at 
the district level.  
 
Both the DHS and the MICS use principal components analysis (PCA)45,46 to construct an asset 
index using data collected on a range of household assets. This asset index is then used to 
construct socio-economic quintiles from the poorest households through to the least poor. The 
DHS are increasing the number of indicators that are presented disaggregated by socio-
economic quintile. Where ad hoc surveys are undertaken the questions asked and methods used 
to construct quintiles are readily available. 
 
 The WHO Regional Office for Africa (AFRO) has suggested creating an information system for 
monitoring of child survival interventions by adding malaria and Integrated Management of 
Childhood Illness (IMCI) to the EPI single page form which is used for monthly reporting at 
district level. The form has been renamed as the “Integrated Child Survival Form”.  A method 
for estimating coverage has been suggested by adding questions on ITN use the night before the 
EPI visit to the section on the number of children vaccinated. The denominator used to 
estimate coverage would then be the number of children immunized. The comparability 
between this estimate and that of population coverage as assessed through survey methods will 
depend upon EPI coverage, with comparability higher with increasing EPI coverage.  
 
In a few cases, programmes have used records of the numbers of nets delivered, divided by the 
size of the intended recipient population, to estimate coverage. Recent surveys in Cambodia 
suggest that this is not a reliable approach. 
 
10.3 Monitoring of outputs 
The indicators for monitoring of outputs and the corresponding methods will vary depending 
upon the delivery channel used. At a minimum they need to measure the numbers of ITNs 
delivered through each system. Within public sector delivery channels this may be as basic as 
the number of ITNs that leave the central distribution point, but much more useful and 
informative would be a system of tracking the ITNs through the various stages in their delivery. 
 
Logistic information on ITNs, retreatment kits, and malaria and IMCI first and second line drugs 
have been added to the information collected in EPI vaccines.  At the output level information 
is collected on the number of women receiving ITNs and IPT at ANC.  
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Tracking the numbers of nets and ITNs delivered through the commercial sector is more 
difficult and we may be better focussing on the outcome level and using identification of nets 
and their source through household surveys as presented above.  
 
10.4 Delivery costs 
The dearth of data on the cost of delivering ITNs through the alternative delivery channels and 
at different scales has been emphasized in this document. The methods used and the definition 
of ‘cost per ITN/net delivered’ vary enormously making comparisons impossible. We suggest 
that as a step-forward in resolving this problem a standard table of costs is used to collect the 
cost data that would include capital costs (i.e. ITNs, vehicles, storage ), recurrent costs (i.e. 
insecticides, delivery costs, fuel, IEC, M&E, training etc) and allowing economies/diseconomies 
of scale. 
 
11. Operational research questions 
Developing this plan was restricted by both a lack of basic health systems information as well as 
technical and cost information.  Listed below are some priority questions the answers to which 
will improve forecasting the number of ITNs needed to cover the target population, the systems 
through which they will best be delivered and the costs of delivery at scale. 
 
11.1 Technical and epidemiological questions 
• What is the effective life of the netting fabrics? 
• What are the relative benefits of covering the different target groups (pregnant women, 
children under 1 year and children 1-4 years) with an ITN? And how can these be assessed? 
• If we have to choose between giving an ITN to the mother through ANC or to the child 
through EPI, which option has greater health benefit? 
• What is the public health value of individual treated and untreated net use compared to no 
net use? 
• What is the shape of the relationship between coverage and the strength of the mass 
effect? 
• How do different levels of insecticidal activity measured in conventional entomological 
tests correspond to epidemiological protection? 
• How can we develop a simplified functional classification of local nets which are made of a 
wide variety of fabrics so that our increased investments develop and strengthen local 
suppliers? 
 
 
11.2 Systems based questions 
• What proportion of pregnant women who attend ANC also take their children for full EPI 
vaccination? 
• Does the delivery of ITNs (free or highly subsidized) through ANC and/or EPI increase 
attendance and therefore coverage? 
• If attendance at ANC and EPI is increased, to what extent and in different contexts is it 
increased? 
• What are the contextual factors that influence the level of increase? 
• How far can we increase coverage of ITNs through EPI outreach? 
• What are the logistical and programmatic hurdles to overcome in a massive scale-up of 
ITNs delivered through routine services? 
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• What are the human resource constraints in this scale-up and how can they be resolved? 
• What is the best way to reach those not accessed through ANC and EPI? And what factors 
affect this? 
• What are the factors that will promote sustainability delivery through the alternative 
channels? 
• To what extent does giving ITNs to target groups through routine services crowd out the 
commercial sector? 
• Does this tendency differ between routine and campaign based delivery systems? 
• Is this exacerbated is several ITNs are given to each family or child? 
• Are existing local suppliers and textile distribution systems better than large importing 
international net manufacturers at providing rural availability and responsiveness to 
increased demand created through voucher schemes? 
• What degree of commercial availability is necessary before campaigns can be designed 
around the use of vouchers? 
• Do voucher schemes inspire more or less cheating than giving ITNs away directly? 
11.3 Household level questions 
• Who uses ITNs delivered through ANC? 
• Do pregnant women use the ITN during pregnancy, or do they save it until their baby is 
born? 
• What proportion of pregnant women sleep under the ITN with children? 
• Who uses the ITN when the child starts to sleep separately from the mother as it gets 
older? 
• What happens to a second ITN when given to a pregnant woman whose children are already 
sleeping under an ITN or an untreated net?  Who uses the new ITN and what factors 
influence this? 
11.4 Costs 
• What are the relative costs of delivering ITNs through alternative channels?  
• How do these costs vary with scale? 
• Does the relative cost of delivery through alternative channels vary depending upon scale 
(i.e. dependent upon relative economies/diseconomies of scale)? 
• What are the relative costs and consequences of alternative strategies for reaching remote 
or disadvantaged populations? 
• What is the cost of national (re)treatment campaigns and what are the factors that affect 
this? 
 
12. Priorities for Action 
The process of compiling this document has highlighted several priorities for action to aid in 
ensuring strategic use of the funds and delivery channels available, so that coverage of the 
target groups with ITNs can be achieved in the most efficient and equitable way depending 
upon the context.  
 
1) Sustained routine delivery of ITNs through ANC should be the priority.  Donor funding needs 
to be channelled in this direction.  Whilst this process is underway, combined delivery of ITNs 
with measles campaigns presents an efficient and equitable way of achieving rapid scale-up in 
the short-term, for those who are part of the target group at the time of the campaign. 
Strategic planning between and within countries is needed to ensure maximum equity and 
minimum overlap in areas and groups covered by catch-up campaigns.  
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2) Household surveys are the method of providing information on outcomes; they are infrequent 
and only provide information down to the regional/provincial level. Household surveys are 
needed every two years at a minimum and ways of obtaining more frequent district level data 
are needed. Programme management tools such as the adapted Integrated Child Health Forms 
need piloting and their usefulness in providing such information needs assessing.  
 
3) Information on the costs of delivering ITNs through the different systems is scant with great 
variability in the costs included. Standard costing methods are needed so that true comparisons 
may be made.  
 
4) There is a need for both guidelines on and technical support to countries in strategic 
planning of delivery of ITNs.  
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Annex 1   SECOND HIGH LEVEL MEETING REPORT 
 
UNITED NATIONS FOUNDATION  
 
 
MEMORANDUM  
 
TO : Participants at the High-Level Donors Meeting on Scaling-Up Insecticide Treated 
Nets, 07 September, Paris, France  
FROM : United Nations Foundation (A. Gay, M. Kimble, K. Starace)  
SUBJECT: Summary of Presentations and Discussions  
DATE : October 12, 2005  
 
SUMMARY  
1. Co-Chairs, Dr A. Asamoa-Baah, Assistant Director-General Communicable Diseases, WHO, 
and Mr. Brad Herbert, Chief of Operations, Global Fund, introduced the meeting by 
emphasizing the importance of having such a sustained forum on scale-up and by welcoming 
new attendees from around the world. New attendees for this meeting included: Ministers 
of Health from Kenya, Malawi, Nigeria, and Sierra Leone, representatives from the Bill and 
Melinda Gates Foundation, Clarke Mosquito Control, Siam Dutch, UNFIP, CDC, World 
Economic Forum, WHO/AFRO, WHO/EPI, and WHOPES.  
2. The purpose of the September 7
th 
meeting in Paris was to move forward the agenda for 
scaling-up LLIN coverage among vulnerable groups in Africa and to identify additional steps 
that must be taken over during the next 12-24 months to achieve the full coverage goal by 
2007-2008.  
 
3. For simplicities sake, a record of the minutes has been broken down into the following 3 
categories:  
 
   A  PROGRESS MADE SINCE JUNE  
 B  KEY DISCUSSION POINTS  
 C  NEXT STEPS FOR THE HIGH-LEVEL GROUP  
 
A PROGRESS MADE SINCE JUNE  
 
4. Organizations reported on particular progress related to agreed-upon assignments from the 
June 23rd Geneva meeting:  
 
5. The Global Fund has set into motion new practices designed to facilitate LLIN direct 
purchase to Principal Recipients (PRs). A joint letter from WHO, GFATM and UNICEF was 
sent to all Principal Recipients in August 2005 informing them of this new purchase option, 
offering template and guidance materials and recommending that countries make the 
switch to LLINs and get orders in as soon as possible. In Geneva, both policy and 
implementation support was provided to GFATM portfolio managers. GFATM is building 
internal systems to improve data collection and reporting capacity (including the Price 
Reporting Mechanism).  As well, detailed country level data on LLIN demand/orders 
provided to MMSS. See, “Joint Mosquito Net Letter (Aug)” and “GF LLIN Procurement 
Considerations”   
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6. UNICEF also sent letters to CCMs requesting forecasts for total country LLIN requirements 
out to the next 3 years. UNICEF said it already had a timeline for completing orders, with 
US$76 Million already registered in the books (15M LLINs - 2006).  
 
7. RBM/MMSS distributed their first quarterly report on LLIN supply and demand and are 
awaiting input back from partners.  
 
8. Canadian CIDA together with United Nations Foundation will fund a Malaria Integration 
Project Manager role at GFATM, to be set up as 2-year position.  
 
9. In response to its task, the World Bank announced that the IFC has engaged a consulting 
firm tasked with finding opportunities to harness the private sector in combating malaria in 
Africa. The study will be run out of its Johannesburg Office and will focus on: (1) production 
and re-treatment of ITNs; (2) capital investment; and (3) distribution and logistics. It’s 
unclear when this study is expected to be finished.  
 
10. WHO strategy paper for LLIN scale-up in Africa was presented at the September 7
th 
meeting.  
 
 
B KEY DISCUSSION POINTS  
 
Supply and Industry:  
 
11. Manufacturers confirmed 2006 capacity figures:  
• Clarke Mosquito Control (Phase II, WHOPES) forecast 1.2 Million/year for 2006 without 
additional investment;  
• Vestergaard, doubling in the next nine months, will be targeting 3.5 Million 
(approximately 48M/yr) for 2006; 
• Sumitomo stated that they produced 2M/yr in 2004 and 7M/y up to September 2005; 
they will be scaling-up production to 15M at the end of 2005 and 24M in 2006 via 11 
factories; 
• Bayer (100 million KO-Tabs 1, 2, 3, with a lead time of less than 4 weeks) offered 
bundled regular nets + retreatment tablets (not long-lasting) for a discounted price in 
order to meet demand. (It was agreed that a realistic strategy for retreatment every six 
months would be needed in order to support such an approach.)  
 
12. Manufacturers pointed out that total 2006 capacity equals 76 Million, yet demand appears 
to be estimated at approximately 50 Million annually for the most vulnerable. (It was made 
clear that Asia and commercial market numbers were not included in this conversation). 
The difference between the various Demand figures and what the Private Sector called a 
"production gap" was an important discrepancy that needs to be clarified. There was 
agreement only on the fact that LLIN Demand figures require further verification and 
validation by all partners.  
 
13. When estimating its own capacity for 2006 – an increase of three times monthly capacity - 
UNICEF pointed out that more supply in the market may actually increase lead-time, as, 
currently, UNICEF estimates an average of 2-3 months for delivery plus 10 months for 
production.  
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14. Private Sector claimed to no longer see value in private procurement agents, because “they 
come in and act as agent for Global Fund and yet they have exclusive agreements with 
certain factories”.  
 
15. The Global Fund presented, “Update on Financing for Insecticide Treated Nets” to update 
the group on current sources of financing allocated for ITNs as well as recipient profiles 
(large and small grants) related to ITN and LLIN purchases. GFATM finances over 60% of 
global ITN demand of which 80% are long lasting.  
 
16. The MMSS quarterly report (now on the web, updated quarterly and sent to all the 
countries) was summarized in a presentation entitled: “A Situation Report on Insecticide 
Treated Nets (ITNs) in AFRICA: Demand, Supply & Funding”.  Regarding its financial 
sustainability, MMSS said human resources were still needed and funding proposals are being 
reviewed.  
 
17. In response to the MMSS report on capacity, the Private Sector said it is happy to report in a 
timely, coordinated fashion, but, in some cases, disputed the figures. “Double reporting” 
and “the serious implications of confidentiality” were maintained as ongoing barriers to 
quality and timely information. It also recognized that MMSS is working with constrained 
financial and human resources. MMSS reiterated that partners are both the sources of data 
and responsible for funding.  
 
18. In response to whether or not manufacturers can speed up production time, the Private 
Sector responded that the dynamics are difficult to convey, and de-bottlenecking the 
delivery systems and the policy impediments is all they could do.  
 
Reaching the poor with ITNs:  
 
19. There is an inadequate supply of LLINs on the global market to make use of all distribution 
opportunities for LLINs linked to measles/polio campaigns in 2006/07. Ethiopia, Kenya and 
Nigeria, for example, were identified as large population countries with planned 
distribution opportunities in 2006, and unmet LLIN needs.  
 
20. For an update on the Measles Immunization campaign, UNF`s Andy Gay and WHO’s Dr. Deo 
Nshimirimana presented a detailed 2006 plan. Planning for any Measles/Malaria campaign 
will take approximately 9 months. Partners called for countries to realize their plans. It was 
estimated that 28M nets are needed by March 2006. Three countries will need 9M nets for 
September to December campaigns in which case, they will need to arrive in country by 
August 2006. Emphasizing the need for early decisions on interventions and financing, the 
Partnership said countries could do net distribution, although not all would be long lasting 
(unless donor commitments were put in place right immediately).  
 
21. Clarke Chemical asked that if approved LLINs were not available would buyers consider 
using non-approved LLINs to supply longer life technology without having to wait for the 
WHOPES completion. WHO said that it thought it would be safer to use approved nets, even 
if other international interventions didn’t require it. Global Fund said that they would work 
with country requests. Vestergaard was willing to create a pipeline based on partial 
shipment and a credit line. 
  
22. Discussions focused on Nigeria and Kenya and the logistics of receiving and distributing such 
large orders (i.e. 140 Containers for 3.4 Million LLINs). The need for changes in country 
procurement practices, such as allowing for partial delivery was a unanimous suggestion 
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from the Private Sector. The group explored various issues surrounding the subject where 
countries discussed feasibility, shipping routes and existing logistical obstacles, concluding 
with the suggestion that countries work closer with suppliers and procurement agents to 
improve the situation.  
 
23. GFATM re-stated its intention to reduce transaction costs to recipient countries and also 
said that if orders can be recorded now for 2007 there should be no problem. ARC pointed 
out that if money is required upfront that might be more of a problem. Determined to work 
this out with “mixed strategies or revised plans as things are better developed”, GFATM is 
aiming to be flexible enough to work within such parameters.  
 
24. The Private Sector and countries reiterated their approval of the discussed direct payment 
models and appreciated the Global Fund’s facilitation, but stressed that such agreements 
are at the discretion of the two procuring parties and therefore requested more information 
on the process and continued engagement in the policy discussion.  
 
25. UNICEF presided over a presentation entitled, Linkages: Expanding the Number of 
Opportunities to Distribute ITNs via Other Delivery Approaches. UNICEF also said it would 
be working more closely with other UN agencies for net distribution, especially World Food 
Programme.  
 
26. Kenya’s Minister of Health emphasized the importance of providing effective and prompt 
treatments immediately for those who are infected; the need to change the treatment (i.e. 
switch to ACTs and LLINs) but to adopt strategies for non-treated nets so as not to miss a 
rainy season; and to engage the entire community in the war on malaria.  
 
27. The Ethiopian Health Minister, working towards a goal of full coverage by 2007, admitted 
that political commitment alone would never achieve what full financing can. Instead of 
relying solely on campaigns – “distribution is not the problem, lack of nets and achieving 
sustainability are the issues”.  Ethiopia is as focused on developing and strengthening health 
systems (e.g. installing health posts in each village), while asserting that DDT “is a must”.  
 
28. The Ministry of Health in Nigeria will use a mix of strategies for 2006, including private 
sector facilities (i.e.: ITN Awareness Schemes, “company mandates to provide ITNs for 
employees and private sector distribution outlets”); free ITNs for certain behaviors (i.e. 
clinic visits); community-based distribution models; furthering the Exxon Mobil voucher 
scheme; ITNs for use in all public and private health facilities (in-patients); and, the 
Measles campaign, which is ongoing in 20 Northern states and in the South by June 2006.  
 
29. Malawi - In 2000, the country began distributing heavily subsidized ITNs. So far, 3.5 million 
nets have gone to children under five. Total ITN coverage is 43% (55% coverage for children 
under five). Some districts have reached their targets, while 6 more may reach them 
shortly. The widespread use of ITNs has played an important part in the decrease of infant 
mortality and under five mortality.  
 
30. Dr. Allan Schapira of the World Health Organization outlined its plan for ITN scale-up with a 
presentation entitled “Attaining Universal Coverage: Protecting Pregnant Women and 
Children under 5 in Africa with ITN. This presentation covered a wide range of issues and 
discussions, namely re-framing the total Demand number by predicting it out over future 
years, across various modes of delivery. Again the institutional discrepancies around global 
demand - and the timelines needed to reach the most vulnerable - were evident, although 
some of this inconsistency might be explained by each organizations different understanding 
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of supply chain management, forecasting and lead time. Discussions evolved surrounding 
scale-up and scale down, reporting and MMSS strengthening, the black market and potential 
market saturation.  
 
Quality:  
 
31. WHOPES re-emphasized its role as strictly a recommendation facility, detailing the ongoing 
work on streamlining that is being done by various committees. WHOPES recommended to 
the group that while it is important to speed up processes at a time of great momentum it’s 
even more critical to do things correctly.  
 
32. Within the context of distribution over the next few years and potential market saturation, 
counterfeits were deemed “a true problem” by various organizations, especially the US and 
the Private Sector. Pointing to WHOPES approval again as the most crucial quality control 
tool, instances where black marketers were/are falsifying a long lasting promise we cited. 
Left unchecked, this could lead to serious damage to the sustainability of the market, and 
the fight against malaria in general.  
 
33. The Private Sector requested status on the conversations previously initiated with WHOPES 
to allow 3
rd 
parties to oversee product standards.  
 
34. In response the US President’s Initiative on Malaria presentation, organizations asked if the 
US would guarantee safe management of insecticides. The US has requested that 3% of 
monies be put aside for insecticide management. The group wondered if this was enough. 
 
35. The Global Fund recommended that issues of quality assurance move towards performance-
based financing so that eventually there would be a ‘gold standard’ in assessment.  
 
C NEXT STEPS FOR THE HIGH-LEVEL GROUP:  
 
36. Letters will go out to all Ministers of Health (similar draft to what was sent to the 
PRs/CCMs) in those countries receiving Global Fund grants to inform them of the new 
policies affecting procurement and direct purchase for LLINs.  
 
37. By the end of the Measles session financing gaps for campaigns were still not completely 
identified and as a result certain distribution opportunities may be missed. A summary of all 
campaign opportunities for LLIN distribution from 2006-2008 will be done jointly by 
WHO/UNF to summarize demand for that timeframe. From there, funding available by 
country needs to be identified and confirmed and communicated to countries and donors. A 
timeline will be set by the Partnership.  
 
38. Comments are needed from Partners on the WHO strategy paper for LLIN scale-up in Africa.  
 
39. More information and coordination was requested regarding an end of year WHOPES 
meeting.  
 
40. At several points in the meeting, various organizations, quite urgently, recommended that 
the malaria community and specifically the High Level group represented here work to 
develop a global task force that would carry this momentum forward on coordination. It was 
widely recommended that WHO and/or RBM take the lead to put into place an agreement 
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by major principal financers on harmonization and financing, technical standards and norms 
as well as overall integration. 
  
41. Action steps were clearly required although not identified with the exception of the RBM 
taking the lead on the continuation of this High Level series, in Cameroon in November, by 
utilizing and synchronizing the work of various and relevant Working Groups.  
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Annex 2 Table I: Total and vulnerable populations at risk of any type malaria, by country 
  
 
 
Country
Total Population 
(2004)
% Population at any 
risk of malaria* Total Under 5 Years Under 1 Years** Pregnant Women
Angola 14,077,616 99 13,914,035 2,769,464 553,893 731,463
Benin 6,918,356 100 6,918,356          1,192,417 238,483 288,798
Burkina Faso 13,393,456 100 13,393,456        2,627,623 525,525 643,388
Burundi 7,067,900 85 5,995,684          1,055,748 211,150 266,468
Cameroon 16,295,931 98 15,965,547        2,410,638 482,128 568,108
CAR 3,911,550 100 3,911,550          621,751 124,350 149,060
Chad 8,853,837 100 8,853,826          1,698,463 339,693 431,975
Comoros 790,094 100 790,094             126,312 25,262 29,187
Congo 3,818,352 100 3,818,352          712,270 142,454 169,808
Cote d'Ivoire 16,896,884 100 16,896,360        2,516,295 503,259 602,978
DRC 54,416,778 94 51,262,243        10,021,151 2,004,230 2,596,828
Eq. Guinea 507,416 99 504,787             88,883 17,777 21,887
Eritrea 4,296,702 99 4,255,791          729,098 145,820 170,494
Ethiopia 72,419,781 64 46,082,953        8,064,430 1,612,886 1,976,959
Gabon 1,351,399 96 1,303,954          184,801 36,960 41,461
Gambia 1,462,434 100 1,462,434          223,776 44,755 52,629
Ghana 21,377,090 100 21,377,090        3,017,784 603,557 682,419
Guinea 8,619,992 100 8,619,992          1,479,060 295,812 372,174
Guinea-Bissau 1,537,710 100 1,530,353          299,948 59,990 77,009
Kenya 32,419,671 78 25,215,377        3,620,098 724,020 824,614
Liberia 3,486,865 100 3,486,865          667,351 133,470 175,218
Madagascar 17,900,935 96 17,212,268        2,991,246 598,249 719,037
Malawi 12,337,267 99 12,245,854        2,245,596 449,119 551,603
Mali 13,408,598 100 13,403,952        2,663,430 532,686 672,359
Mauritania 2,980,358 100 2,974,978          511,884 102,377 125,281
Mozambique 19,182,366 100 19,153,158        3,178,614 635,723 798,449
Namibia 2,010,788 41 820,603             123,312 24,662 27,507
Niger 12,414,998 100 12,400,752        2,642,742 528,548 688,747
Nigeria 127,117,325 100 127,111,873      21,179,913 4,235,983 5,000,179
Rwanda 8,481,216 67 5,651,046          1,016,543 203,309 251,095
Sao Tome & Prin. 164,619 100 164,619             25,030 5,006 5,493
Senegal 10,339,004 100 10,339,004        1,663,549 332,710 385,767
Sierra Leone 5,168,349 100 5,167,596          969,507 193,901 261,005
Somalia 10,312,172 99 10,203,196        2,086,229 417,246 534,793
Sudan, North 34,333,410 99 33,898,177        4,866,233 973,247 1,126,224
Sudan, South - - - - - -
Swaziland 1,082,961 77 829,765             125,171 25,034 28,664
Tanzania 37,671,095 96 36,211,072        5,975,153 1,195,031 1,428,963
Togo 5,017,293 100 5,017,293          821,413 164,283 193,901
Uganda 26,699,283 93 24,843,791        5,166,334 1,033,267 1,266,953
Zambia 10,924,255 99 10,821,156        1,908,917 381,783 459,763
Zimbabwe 12,932,074 84 10,887,513        1,581,507 316,301 351,990
TOTAL 664,398,180 614,916,765 105,869,684 21,173,937 25,750,698
Population for Any Risk Malaria (2004)
* MARA/ARMA, 2005                                                  **Crude estimate: population under five years divided by five  
  Source:      
1) UNPOP. World Population Prospects: 2002 Revision Population Database. http://esa.un.org/unpp ed: Population Division of the 
Department of Economic and Social Affairs of the United Nations Secretariat, 2003.  
2) Population projections for 2004 were obtained courtesy of John Miller, WHO 
3) Population of pregnant women calculated as number of live births minus number of maternal deaths in pregnancy, courtesy of 
WHO
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Annex 2 Table II: Population projections for pregnant women and under five year olds (2006-2010), by country 
 
No. <1s
COUNTRY 2006 2007 2008 2009 2010 2006 2007 2008 2009 2010 2004
Angola 749,261 772,195 795,257 818,475 841,886 2,944,203 3,023,788 3,099,562 3,173,390 3,246,752 657,275
Benin 290,611 298,189 305,881 313,692 321,621 1,242,082 1,267,486 1,292,598 1,316,650 1,339,039 310,276
Burkina Faso 660,781 680,805 701,451 722,711 744,580 2,769,306 2,843,100 2,918,037 2,993,154 3,067,754 539,029
Burundi 297,411 307,785 318,266 328,661 338,831 1,147,770 1,200,615 1,255,445 1,309,223 1,359,595 248,957
Cameroon 543,201 551,233 558,998 566,552 573,944 2,438,121 2,448,289 2,455,708 2,459,847 2,460,426 513,471
CAR 147,432 149,597 151,875 154,206 156,544 629,032 634,078 639,754 645,643 651,409 138,326
Chad 444,048 457,209 470,706 484,528 498,667 1,800,998 1,850,463 1,898,469 1,944,805 1,989,356 407,029
Comoros 28,404 29,180 29,963 30,749 31,535 130,851 132,888 134,701 136,221 137,402 26,283
Congo 174,173 179,282 184,655 190,190 195,812 749,467 768,351 787,299 806,175 824,873 157,659
Cote d'Ivoire 586,058 595,227 604,441 613,633 622,751 2,560,641 2,579,784 2,596,187 2,609,121 2,618,087 605,489
DRC 2,660,780 2,738,882 2,818,208 2,899,073 2,981,695 10,700,501 10,985,925 11,243,840 11,485,757 11,720,421 2,343,580
Eq. Guinea 21,832 22,391 22,955 23,526 24,102 93,078 94,818 96,379 97,845 99,277 19,124
Eritrea 170,928 177,022 183,072 188,938 194,521 767,463 786,355 804,330 820,610 834,661 151,708
Ethiopia 1,982,985 2,030,720 2,079,370 2,129,049 2,179,828 8,355,286 8,505,687 8,659,056 8,814,874 8,972,458 1,807,085
Gabon 39,278 40,017 40,778 41,548 42,317 186,168 186,754 187,318 187,894 188,504 38,378
Gambia 50,155 51,346 52,529 53,700 54,856 228,659 230,661 232,338 233,661 234,618 48,370
Ghana 656,662 670,137 683,617 697,078 710,499 3,082,803 3,107,942 3,128,423 3,144,669 3,157,089 642,437
Guinea 360,325 369,596 379,708 390,121 400,431 1,518,533 1,550,251 1,585,727 1,619,560 1,647,826 352,474
Guinea-Bissau 77,601 79,864 82,177 84,549 86,985 316,069 323,191 329,986 336,836 344,022 68,754
Kenya 785,223 795,360 805,427 815,321 824,967 3,632,896 3,636,567 3,638,240 3,637,931 3,635,662 949,155
Liberia 180,232 185,350 190,307 195,278 200,394 710,808 729,416 746,374 762,426 778,153 144,621
Madagascar 713,427 733,309 753,553 774,154 795,106 3,102,539 3,158,909 3,215,276 3,271,095 3,325,926 630,674
Malawi 538,142 548,224 558,437 568,853 579,525 2,279,320 2,299,884 2,322,710 2,347,644 2,374,537 501,078
Mali 703,829 726,459 749,987 774,342 799,471 2,839,621 2,931,886 3,024,816 3,115,983 3,203,649 577,369
Mauritania 125,837 129,409 133,007 136,631 140,285 537,869 549,952 561,267 571,658 581,032 112,920
Mozambique 771,168 782,974 794,691 806,404 818,171 3,245,376 3,267,382 3,284,032 3,297,907 3,310,901 713,223
Namibia 24,761 24,983 25,189 25,385 25,574 120,635 119,099 117,570 116,193 115,077 22,491
Niger 708,665 734,547 761,244 788,773 817,159 2,829,302 2,918,886 3,007,121 3,095,513 3,185,255 645,203
Nigeria 4,883,215 4,997,793 5,112,580 5,227,686 5,343,159 21,768,651 22,046,554 22,310,561 22,557,637 22,785,204 4,868,478
Rwanda 244,651 249,480 255,032 260,710 266,301 1,043,863 1,058,282 1,072,125 1,084,522 1,094,857 218,587
Sao Tome & Prin. 5,282 5,413 5,546 5,679 5,811 25,648 25,903 26,116 26,279 26,392 4,803
Senegal 378,555 387,460 396,447 405,479 414,527 1,719,849 1,743,812 1,764,727 1,782,403 1,796,751 389,846
Sierra Leone 263,211 268,508 272,895 277,062 281,519 991,182 1,006,115 1,016,183 1,024,633 1,033,860 211,867
Somalia 551,186 572,800 594,565 616,478 638,554 2,252,790 2,330,704 2,405,190 2,476,910 2,546,510 320,258
Sudan, North 1,055,066 1,074,773 1,094,024 1,112,981 1,131,768 4,900,303 4,907,028 4,908,322 4,905,825 4,900,940 1,087,445
Sudan, South -
Swaziland 26,248 26,253 26,228 26,187 26,142 122,592 121,018 119,363 117,752 116,276 22,020
Tanzania 1,386,728 1,411,477 1,436,556 1,462,233 1,488,682 6,037,371 6,073,920 6,112,702 6,151,654 6,189,055 1,247,094
Togo 190,692 195,014 199,422 203,876 208,346 843,761 855,383 866,903 877,863 887,919 214,710
Uganda 1,314,069 1,361,488 1,411,157 1,462,740 1,515,990 5,526,041 5,704,567 5,882,802 6,061,669 6,241,878 1,190,746
Zambia 450,588 456,098 461,958 468,147 474,640 1,927,441 1,938,442 1,950,852 1,964,832 1,980,404 429,581
Zimbabwe 337,492 337,907 338,175 338,346 338,461 1,563,792 1,556,028 1,548,794 1,541,760 1,534,650 307,162
TOTAL 25,580,193 26,205,756 26,840,334 27,483,724 28,135,957 109,682,681 111,500,163 113,247,203 114,926,024 116,538,457 23,885,034
No. pregnant women No. <5s
Sou
rce:      
Source:  UNPOP. World Population Prospects: 2002 Revision Population Database. http://esa.un.org/unpp ed: Population Division of the Department of Economic and Social Affairs of 
the United Nations Secretariat, 2003. Courtesy of John Miller, WHO  
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Annex 2 Table III: Planned measles campaigns by country (2005–2008)  
 
COUNTRY
Planned Campaign 
Date Campaign Type
Planned ITN 
Integration
Action Plan Target 
Group*
Angola Aug-06 Follow up Y 2,944,203
Benin Dec-05 Follow up Y -
Burkina Faso 2007 Follow up 2,843,100
Burundi Jun-06 Follow up 1,147,770
Cameroon Jan-06 Follow up Y? 2,438,121
CAR Nov-05/Jan-06 Catch up 629,032
2008 Follow up
Chad Sep-05 Catch up
Jan-06 Catch up 1,800,998
Comoros - - -
Congo 2007 Follow up 768,351
Cote d'Ivoire Aug-05 Catch up
2007 Follow up 2,579,784
DRC Oct-05 Catch up -
Eq. Guinea Sep-05 Catch up Y -
Eritrea 2007 Follow up 786,355
Ethiopia Jun-05 Follow up -
Gabon 2005 Catch up -
Gambia 2007 Follow up 230,661
Ghana Sep-06/Dec-06 Follow up 3,082,803
Guinea 2007 Follow up 1,550,251
Guinea-Bissau - - -
Kenya Aug-06 Follow up Y? 3,632,896
Liberia 2006 Follow up 710,808
Madagascar - - -
Malawi Aug-05 Follow up -
Mali - - -
Mauritania 2007 Follow up 549,952
Mozambique Sep-05 Catch up Y -
Namibia 2007 Follow up 119,099
Niger Oct-05 Catch up Y? -
Nigeria Jun-06 - Y 21,768,651
Rwanda 2006 Follow up Y 1,043,863
Sao Tome & Prin. Jan-06 Follow up 25,648
Senegal 2006 Follow up 1,719,849
Sierra Leone May-06 Follow up Y 991,182
Somalia May-06/2007 Catch up 2,252,790
Sudan, North Sep-05 Catch up -
Sudan, South Nov-05/Jan-06 Catch up -
Swaziland 2006 Follow up 122,592
Tanzania - - -
Togo - - -
Uganda 2006 Follow up 5,526,041
Zambia 2006 Follow up 1,927,441
Zimbabwe May-06 Follow up Y? 1,563,792
TOTAL 62,756,033
* National population of under five year olds (not excluding <9 months)
? Indicates uncertainties during planning process which may delay integrated campaign  
Source: courtesy of WHO 
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Annex 2 Table IV: Existing estimates of ITNs and funds needed to reach RBM and/or malaria MDGs 
Study Objective
Total Vulnerable Target 
Population (PW & U5s) How calculated Major assumptions
Number of ITNs 
needed How calculated Major assumptions Cost (USD) How calculated Major assumptions
122,774,000 (popn)
Total U5s + total 
pregnant women 
U5 data directly from World 
Population Prospects 
Population Database; PW 
derived from number of 
pregnancies (live births+ 
maternal deaths during 
pregnancy); population data 
from same year as net survey 92.3 million
HH with PW&U5 in risk 
areas x 1.09 (60% 
targeted coverage/ 55% 
usage by target groups) 
x popn growth rate (to 
2005) 
All nets targeted to HH 
with PW & U5s in areas 
at risk; 55% nets owned 
in areas at risk used by 
PW & U5s 258.4 million
92.3m ITNs x 
USD 2.80
111,597,000 HH
?? HH with U5s + 
HH with PW 
(independent??)
Proportion of HH with U5 or 
woman 15-49 years from 
MICS; Ratio of PW: women 
used to calculate proportion 
and number of HH with PW 136.1 million
HH in risk areas x 1.09 
(60% targeted 
coverage/ 55% usage) x 
popn growth rate (to 
2005)
ITNs equally distributed 
over areas at risk and 
not at risk 381.1 million
136.1m ITNs x 
USD 2.80
169.3million
HH with PW&U5 in risk 
areas x 2 ITNs x popn 
growth rate (to 2005)
Fixed 2 ITNs for all HH 
in risk areas with PW & 
U5s 474.0 million
169.3m ITNs x 
USD 2.80
Kiszewski et al (in 
process) An estimate 
of the total costs of the 
interventions required 
at country level from 
2005-2015 to reach 
international malaria 
control goals.
Estimate costs 
needed to support 
minimal set of 
interventions (incl. 
ITNs) required to 
acheve 2010 Abuja 
targets and 2015 
malaria MDG
205,000,000 (worldwide) 
?136,790,000 Africa 
30m PW + 175m 
U5s 
Highly vulnerable popn 
defined as PW & U5s living in 
areas where more likely than 
not to be exposed to 
P.falciparum  infection within 
given year; Figures from 
UNPOP statistics and World 
Fertility Report (age-specific 
fertility rates)  
1.66 billion 
(ranges by year 
from 95.7m-
223.3m)
Gradual increase in 
ITN coverage from 
2005-2015 to achieve 
95% by 2015; One 
net between two 
people; Lifespan of 
net 3 years (costs 
include replacement); 
USD 7.00 per net 
(USD 6.00 median 
cost of LLIN from 
RBM "Sources & 
Prices", USD 1.00 
distribution costs)
UN Millennium Project 
(2005) Coming to 
grips with malaria in 
the new millennium: 
Estimated costs of 
scaled-up malaria 
control efforts in 
Ethiopia, 2005-2015.
Reduce malaria 
burden by half by 
2010 and by a further 
50% by 2015 - 
increase bednet 
coverage from 45% in 
2005 to 100% in 2007 
and maintain until 
2015 for all living in 
malarious area
14.9 million (2005) 
79.6 million (cumulative 
total 2005-2015)
Total popn (73m) x 
Popn at risk of 
malaria (68%) x at-
risk population 
eligible for ITN 
(30%)
Unclear wher 30% 'eligible' 
figure came from - proportion 
needed to reach 45% 
coverage? U5s & PW? 4 million (2005)
No. eligible HH x 3 ITNs 
per HH - existing ITNs 
No. HH taken as 
eligible popn/ 5 people; 
for successive years, 
recipients those without 
ITNs previous year + 
new popn at risk due to 
popn growth (3%)
29.36 million 
(2005)     273.9 
million (total to 
2015)
2005: New nets 
(4m ITNs x USD 
7.00) + 
Retreatment 
(3m x USD 
0.40). Total: No. 
nets needed 
every year to 
reach and 
maintain 100% 
coverage x USD 
7.00. 
USD 7.00 per new net 
(USD 5.00 purchase 
price + USD 2.00 
handling, storage and 
distribution); Initial 
cost of retreating 3m 
existing nets in 
country (USD 
0.4/net); Replacement 
nets every 4 years 
USD 2.80 cost per net 
delivered: UNICEF 
bulk purchase price of 
USD 1.40 per net + 
USD 1.40 delivery 
costs incl. wages, 
allowances, admin, 
transport (Curtis et al, 
2003) 
Miller et al (in process) 
Monitoring the number 
of mosquito nets in 
African households 
south of the Sahara.
Estimate no. ITNs 
currently available and 
needed to reach Abuja 
target of 60% net 
usage by PW & U5s 
by 2005
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Annex 2 Table V: Estimated numbers covered by catch-up (ANC, EPI) and keep-up (combined campaigns) strategies 
 
COUNTRY Campaigns ANC EPI Campaigns ANC EPI ANC EPI ANC EPI ANC EPI
Angola 2,433,856 471,285 272,525 485,711 279,231 500,217 285,924 514,821 292,566 529,546 299,121
Benin 256,610 163,203 263,301 166,754 270,093 170,165 276,990 173,391 283,991 176,399
Burkina Faso 478,405 233,389 2,285,419 492,903 239,326 507,851 245,148 523,243 250,811 539,076 256,298
Burundi 901,511 255,773 183,955 264,695 193,761 273,709 203,541 282,648 212,985 291,395 221,770
Cameroon 2,054,402 429,129 235,604 435,474 235,770 441,608 235,828 447,576 235,825 453,416 235,795
CAR 526,957 98,779 53,487 100,230 53,852 101,756 54,225 103,318 54,598 104,884 54,952
Chad 1,477,963 142,095 95,942 146,307 98,991 150,626 102,006 155,049 104,966 159,573 107,852
Comoros 24,143 14,643 24,803 14,748 25,469 14,834 26,137 14,905 26,805 14,962
Congo 119,134 72,507 598,744 122,629 74,748 126,304 77,024 130,090 79,325 133,935 81,637
Cote d'Ivoire 491,117 272,379 1,989,261 498,800 273,729 506,522 274,983 514,224 276,156 521,865 277,241
DRC 1,423,517 944,431 1,465,302 973,721 1,507,741 1,002,791 1,551,004 1,031,308 1,595,207 1,058,898
Eq. Guinea 14,933 8,597 15,315 8,809 15,701 9,015 16,092 9,213 16,486 9,399
Eritrea 120,333 103,790 622,001 124,623 106,223 128,883 108,441 133,012 110,431 136,943 112,188
Ethiopia 531,440 568,438 544,233 576,690 557,271 584,808 570,585 592,699 584,194 600,285
Gabon 36,882 16,202 37,576 16,200 38,291 16,209 39,014 16,233 39,736 16,271
Gambia 45,992 31,935 182,274 47,084 32,065 48,169 32,168 49,243 32,257 50,303 32,341
Ghana 2,598,266 591,652 403,135 603,793 405,148 615,939 407,003 628,067 408,731 640,160 410,346
Guinea 252,588 137,524 1,198,301 259,087 139,141 266,175 140,767 273,475 142,419 280,702 144,111
Guinea-Bissau 53,157 37,910 54,707 39,008 56,291 40,087 57,916 41,145 59,585 42,185
Kenya 2,653,360 689,426 710,164 698,326 727,365 707,165 742,332 715,852 754,742 724,321 764,360
Liberia 600,071 123,279 63,120 126,779 64,482 130,170 65,867 133,570 67,301 137,069 68,798
Madagascar 575,022 332,938 591,047 337,232 607,364 341,441 623,968 345,552 640,855 349,556
Malawi 508,006 312,433 517,523 316,063 527,165 320,025 536,997 324,326 547,072 328,969
Mali 366,695 215,197 378,485 220,307 390,743 225,460 403,432 230,637 416,524 235,836
Mauritania 79,151 54,012 433,797 81,398 54,918 83,661 55,734 85,941 56,464 88,239 57,112
Mozambique 647,781 404,807 657,698 407,402 667,540 409,847 677,379 412,204 687,264 414,549
Namibia 21,022 31,999 66,033 21,211 31,960 21,385 32,023 21,552 32,184 21,712 32,439
Niger 279,214 174,678 289,412 178,973 299,930 183,426 310,777 188,065 321,961 192,912
Nigeria 18,149,214 2,978,761 1,299,378 3,048,654 1,311,811 3,118,674 1,323,340 3,188,888 1,333,888 3,259,327 1,343,310
Rwanda 788,902 226,302 209,323 230,769 213,439 235,905 217,069 241,157 220,221 246,328 222,868
Sao Tome & Prin. 22,016 4,912 2,848 5,034 2,867 5,158 2,879 5,281 2,886 5,404 2,886
Senegal 1,424,740 311,551 180,607 318,880 182,388 326,276 184,001 333,709 185,425 341,156 186,639
Sierra Leone 828,546 178,983 100,021 182,585 102,534 185,569 104,877 188,402 107,040 191,433 109,040
Somalia 2,006,159 323,546 92,487 336,234 94,308 349,010 96,065 361,873 97,744 374,831 99,335
Sudan, North 701,619 430,287 714,724 431,203 727,526 431,951 740,132 432,601 752,626 433,193
Sudan, South 0 0 0 0 0 0 0 0 0 0
Swaziland 102,236 24,411 15,959 24,415 15,844 24,392 15,761 24,354 15,705 24,312 15,673
Tanzania 1,307,685 757,859 1,331,023 759,676 1,354,672 761,257 1,378,886 762,713 1,403,827 764,092
Togo 156,367 92,389 159,911 93,419 163,526 94,359 167,178 95,219 170,844 96,006
Uganda 4,471,353 1,207,629 599,063 1,251,207 622,977 1,296,853 647,307 1,344,258 671,825 1,393,195 696,269
Zambia 1,602,502 420,849 274,249 425,996 277,069 431,469 279,906 437,249 282,746 443,314 285,553
Zimbabwe 1,293,411 313,868 213,871 314,254 214,285 314,503 214,733 314,662 215,124 314,769 215,365
TOTAL 43,935,463 17,283,046 10,417,286 7,375,830 17,692,139 10,588,437 18,107,270 10,754,626 18,528,002 10,914,579 18,954,185 11,066,812
2006 2007 2008 2009 2010
 
 
Source:  UNPOP. World Population Prospects: 2002 Revision Population Database. http://esa.un.org/unpp ed: Population Division of the Department of Economic and Social 
Affairs of the United Nations Secretariat, 2003. Courtesy of John Miller, WHO 
Campaigns data includes children aged 9-59 months, assuming 100% coverage 
ANC data includes projections on the population of pregnant women at the latest ANC coverage levels 
EPI data includes projections on the population of children aged 0-9 months at the latest EPI coverage
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Annex 2 Table VI: Calculations of coverage achieved by each delivery strategy  
 
 
Total <5s
No. <5s 
covered (ANC 
Only)
No. <5s covered     
(ANC & EPI)
Total pregnant 
women
No. pregnant 
women covered
Total <5s and 
pregnant women
Total <5s and 
pregnant women 
covered (ANC & 
EPI)
Propn of <5s and 
pregnant women 
covered (ANC & 
EPI)
Total <5s and 
pregnant 
women 
covered (ANC)
Propn <5s and 
pregnant 
women 
covered (ANC)
2006 109,682,681 53,328,480 66,104,748 25,580,193 17,283,046 135,262,874 83,387,794 61.6 70,611,526 52.2
2007 111,500,163 69,373,383 94,925,919 26,205,756 17,692,139 137,705,919 112,618,058 81.8 87,065,522 63.2
2008 113,247,203 57,231,269 95,560,073 26,840,334 18,107,270 140,087,537 113,667,343 81.1 75,338,539 53.8
2009 114,926,024 23,763,802 62,092,606 27,483,724 18,528,002 142,409,748 80,620,608 56.6 42,291,804 29.7
2010 116,538,457 18,528,002 56,856,806 28,135,957 18,954,185 144,674,414 75,810,991 52.4 37,482,187 25.9
2006
2007
2008
2009
2010
* PW = pregnant women
100% Coverage of Target Population
All 2006 <5s + all 2006 PW 
2007 PW
2008 PW
3-5s from 2006 + 2009 PW
3-4s from 2007 +  2010 PW
Catch-up & Keep-up Coverage of <5s and PW
1-4s from 2006 measles campaign + <5s from 2007 measles 
campaigns + <1s from 2006 ANC + routine measles 2007 + routine 
measles 2006 + PW from 2007 ANC
2-4s from 2006 measles campaigns + 1-4s from 2007 measles 
campaigns + <1s from 2007 ANC + routine measles 2008 + routine 
measles 2007 + routine measles 2006 + PW from 2008 ANCp g
measles 2009 + routine measles 2008 + routine measles 2007 + PW 
from 2009 ANC
<1s from 2009 ANC +routine measles 2010 + routine measles 2009 + 
routine measles 2008+ PW from 2010 ANC
2-4s from 2007 measles campaigns + <1s from 2008 ANC + PW from 2009 ANC
Campaigns & ANC & EPI
<5s from 2006 measles campaigns + routine measles 2006 + PW 
through 2006 ANC<5s from 2006 measles campaigns + PW through 2006 ANC
Campaigns & ANC Only
1-4s from 2006 measles campaign + <5s from 2007 measles campaigns + <1s from 
2006 ANC + PW from 2007 ANC
2-4s from 2006 measles campaigns + 1-4s from 2007 measles campaigns + <1s from 
2007 ANC + PW from 2008 ANC
<1s from 2009 ANC + PW from 2010 ANC
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Annex 2 Table VII: National antenatal clinic and vaccination coverage, by country 
 
WHO/UNICEF       
(2004)
Country Data Source
National ANC 
Coverage
National DPT1 
Coverage
National DPT3 
Coverage
National DPT3 
Coverage
Angola MICS 2000 62.9 55.8 33.9 59.0
Benin DHS 2001 88.3 87.2 72.5 83.0
Burkina Faso DHS 2003 72.4 76.1 57.0 88.0
Burundi* MICS 2000 86.0 86.0 70.1 74.0
Cameroon MICS 2000, 
DHS 1998 79.0 68.7 44.6 73.0
CAR DHS 1994/95 67.0 75.6 47.5 40.0
Chad MICS 2000, 
DHS 1996/97 32.0 45.1 20.7 50.0
Comoros  MICS 2000, 
DHS 1996/97 85.0 72.8 69.6 76.0
Congo** 68.4 66.7 46.0 67.0
Cote d'Ivoire MICS 2000 83.8 78.7 61.9 50.0
DRC* MICS 2001 53.5 53.5 30.7 64.0
Eq. Guinea** 68.4 66.7 46.0 33.0
Eritrea DHS 2002 70.4 90.6 82.8 83.0
Ethiopia DHS 2000 26.8 44.4 20.7 80.0
Gabon DHS 2000 93.9 69.4 37.6 38.0
Gambia* MICS 2000 91.7 91.7 72.2 92.0
Ghana DHS 2003 90.1 90.8 79.5 80.0
Guinea DHS 1999 70.1 71.9 46.2 69.0
Guinea Bissau* MICS 2000 68.5 68.5 37.7 80.0
Kenya DHS 2003 87.8 89.2 72.2 73.0
Liberia** 68.4 66.7 46.0 31.0
Madagascar MICS 2000 80.6 74.4 63.0 61.0
Malawi DHS 2000 94.4 95.9 84.2 89.0
Mali DHS 2001 52.1 61.0 39.6 76.0
Mauritania DHS 2000/01 62.9 70.0 39.9 70.0
Mozambique DHS 2003 84.0 87.6 71.6 72.0
Namibia DHS 2000 84.9 92.0 79.3 81.0
Niger
MICS 2000, 
DHS 1998 39.4 43.2 28.1 62.0
Nigeria DHS 2003 61.0 42.6 21.4 25.0
Rwanda DHS 2000, 
MICS 2000 92.5 90.3 80.9 89.0
Sao Tome & 
Principe*
MICS 2000
93.0 93.0 79.7 99.0
Senegal MICS 2000, 
DHS 1999 82.3 73.3 50.0 87.0
Sierra Leone* MICS 2000 68.0 68.0 45.5 61.0
Somalia* MICS 1999 58.7 58.7 35.6 30.0
Sudan (North)* MICS 2000 66.5 66.5 44.1 55.0
Sudan (South) MICS 2000 21.1 22.2
Swaziland* MICS 2000 93.0 93.0 78.6 83.0
Tanzania/ 
Zanzibar
DHS 2004
94.3 93.3 85.9 95.0
Tanzania 
(Zanzibar)
DHS 2004
98.8 95.5 88.6 98.8
Togo MICS 2000 82.0 81.4 56.6 71.0
Uganda DHS 2000/01 91.9 77.0 46.1 87.0
Zambia DHS 2001/02 93.4 94.1 80.0 80.0
Zimbabwe DHS 1999 93.0 87.5 80.9 85.0
80.6 75.0 53.3 73.0
Survey Data
* Missing ANC coverage data calculated using median ratio of ANC/DPT1 coverage
** Missing survey data calculated using mean ANC/DPT1/DPT3 data from Cote d'Ivoire, DRC, Sierra Leone (as proxy complex 
MEDIAN
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Annex 2 Table VIII: Funds allocated and disbursed for malaria control 
 
Country
Allocated Funds 
(USD) 
Maximum 5 Year 
Funds
Amount 
Disbursed by July 
2004* (USD) Donor Funded Years
Angola 25,259,000 38,383,000 11,260,370 GFATM (R3)
Benin 2,389,185 2,973,150 2,317,139 GFATM (R1)
1,383,931 2,145,813 816,495 GFATM (R3)
Burkina Faso 7,144,703 7,144,703 2,925,513 GFATM (R2)
Burundi 13,792,126 17,766,125 12,930,062 GFATM (R2)
Cameroon 16,938,794 32,770,143 5,418,552 GFATM (R3)
CAR 10,952,816 17,857,057 1,872,782 GFATM (R4)
Chad 3,028,688 8,030,340 - GFATM (R3)
Comoros 1,534,631 2,485,878 599,483 GFATM (R2)
Congo - - - -
Cote d'Ivoire - - - -
DRC 24,966,696 53,936,609 5,755,998 GFATM (R3)
6,153,100 - - DFID 2003-2005
Eq. Guinea - - - -
Eritrea 2,617,633 7,911,425 1,080,215 GFATM (R2)
Ethiopia 37,915,012 76,875,212 32,600,733 GFATM (R2)
2,244,250 - - DFID 2005-2006
Gabon 7,419,625 9,892,185 1,224,253 GFATM (R4)
Gambia 5,665,500 13,861,866 3,104,829 GFATM (R3)
Ghana 4,596,111 9,356,933 4,088,709 GFATM (R2)
18,561,367 38,887,781 7,355,508 GFATM (R4)
Guinea 6,893,509 8,798,945 1,398,095 GFATM (R2)
Guinea-Bissau 1,885,791 4,177,512 192,906 GFATM (R4)
Kenya 10,526,880 33,586,810 4,640,447 GFATM (R2)
81,972,711 186,319,508 - GFATM (R4)
49,912,120 - - DFID 2002-2006
24,417,440 - - DFID 2007
Liberia 12,140,921 12,140,921 6,184,615 GFATM (R3)
Madagascar 1,120,476 2,000,064 1,750,299 GFATM (R1)
5,232,448 10,400,722 2,764,778 GFATM (R3)
19,304,060 41,527,527 10,741,254 GFATM (R4)
Malawi 20,872,000 39,688,000 - GFATM (R2)
- - - DFID 2002-2005
Mali 2,023,424 2,592,991 1,412,336 GFATM (R1)
Mauritania 824,125 2,899,074 680,999 GFATM (R2)
Mozambique 12,273,573 28,205,783 6,653,718 GFATM (R2)
15,260,900 - - DFID 2005
Namibia 3,719,354 6,304,577 1,720,424 GFATM (R2)
Niger 4,815,109 5,886,835 2,882,940 GFATM (R3)
Nigeria 17,828,808 44,314,691 8,706,992 GFATM (R2)
20,467,000 86,122,000 4,268,800 GFATM (R4)
3,815,225 - 2,125,000 DFID 2004
143,632,000 - - DFID 2005-2010
Rwanda 13,045,301 17,676,240 7,428,843 GFATM (R3)
1,436,914 - - DFID 2003-2005
Sao Tome & Prin. 1,941,359 3,484,859 906,331 GFATM (R4)
Senegal 4,285,714 7,142,857 1,526,770 GFATM (R1)
23,745,283 33,871,668 - GFATM (R4)
Sierra Leone 12,096,834 18,805,137 2,043,498 GFATM (R4)
Somalia 8,890,497 12,866,413 6,123,033 GFATM (R2)
Sudan, North 14,237,853 33,240,453 8,263,670 GFATM (R2)
- - - DFID 2005-2007
Sudan, South 12,855,490 27,827,045 4,903,414 GFATM (R2)
Swaziland 978,000 1,864,500 614,500 GFATM (R2)
Tanzania 11,959,076 19,872,716 8,790,612 GFATM (R1)
54,201,787 90,468,963 - GFATM (R4)
16,158,600 - - DFID 1998-2007
Tanzania (Zanzibar) 781,220 1,153,080 781,220 GFATM (R1)
5,089,361 9,586,972 2,792,077 GFATM (R4)
Togo 3,479,337 5,885,906 2,146,271 GFATM (R3)
6,374,288 11,003,235 - GFATM (R4)
Uganda 23,211,300 35,783,000 9,749,358 GFATM (R2)
66,432,148 158,047,079 - GFATM (R4)
1,436,320 - 800,000 DFID 2003-2004
1,885,170 - - DFID 2004-2007
Zambia 17,892,000 39,274,000 17,891,800 GFATM (R1)
20,279,950 43,495,950 - GFATM (R4)
5,386,200 - - DFID 2004-2005
Zimbabwe 6,716,250 8,877,500 5,276,938 GFATM (R1)
2,764,916 - - DFID 2003-2006
TOTAL 989,062,210 1,435,471,753 229,512,579
* NOTE: total funds disbursed do not include those already disbursed by DFID or some GFTAM grants (data 
unavailable)  
Source: GFATM data courtesy of WHO, DFID data courtesy of Africa Policy Division DFID 
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Annex 2 Table IX: Number of nets sold/disbursed (2000-2003), by country 
 
Country 2000 2001 2002 2003 TOTAL
Angola 120,086 157,752 431,280 364,940 1,074,058
Benin - - 408,000 - 408,000
Burkina Faso 14,988 5,396 28,252 41,515 90,151
Burundi - - - 210,000 210,000
Cameroon - - 12,930 105,233 118,163
CAR - 5,050 5,250 7,500 17,800
Chad 2,000 1,000 5,100 49,000 57,100
Comoros 5,100 2,500 25,000 6,800 39,400
Congo - 1,000 2,000 4,250 7,250
Cote d'Ivoire - 9,266 11,204 - 20,470
DRC 6,000 119,186 53,000 365,100 543,286
Eq. Guinea - 16,000 14,000 16,000 46,000
Eritrea 97,324 67,708 276,038 187,709 628,779
Ethiopia - 237,000 378,900 331,900 947,800
Gabon - - - - -
Gambia - - 32,260 - 32,260
Ghana - - 60,000 85,030 145,030
Guinea - - 40,000 - 40,000
Guinea-Bissau 40,000 - 4,000 189,000 233,000
Kenya 32,300 267,200 200,000 684,850 1,184,350
Liberia 3,700 13,800 - - 17,500
Madagascar 11,100 134,971 123,871 148,871 418,813
Malawi 41,835 46,062 149,065 1,052,418 1,289,380
Mali - 64,000 189,000 439,897 692,897
Mauritania 13,432 9,001 989 30,893 54,315
Mozambique 219,344 104,277 130,326 205,993 659,940
Namibia - 1,000 18,000 - 19,000
Niger 2,600 34,353 36,127 121,000 194,080
Nigeria 70,000 145,000 1,161,925 1,535,718 2,912,643
Rwanda 70,870 115,309 88,010 269,210 543,399
Sao Tome & Prin. - 4,840 6,393 7,864 19,097
Senegal - - - 881,000 881,000
Sierra Leone 14,300 - - - 14,300
Somalia - - 80,839 55,839 136,678
Sudan, North - 200,000 108,090 211,520 519,610
Sudan, South - - - - -
Swaziland - - - 1,200 1,200
Tanzania 63,556 103,522 640,039 1,466,181 2,273,298
Togo 10,789 13,500 30,613 85,000 139,902
Uganda 100,000 250,000 280,295 467,081 1,097,376
Zambia 115891 260881 378090 272,462 1,027,324
Zimbabwe - 72,000 - 90,000 162,000
TOTAL 1,055,215 2,461,574 5,408,886 9,990,974 18,916,649
Number Nets Sold/ Distributed (WMR*, UNICEF)
* WMR = World Malaria Report 2005  
 
               Source: WHO/UNICEF. World Malaria Report 2005. WHO/MAL/2005.1102. Geneva.  
